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ZUSAMMENFASSUNG 
Chlamydia trachomatis ist ein obligat intrazellulär lebendes, gram-negatives Bakterium. Es 
wird mit einer Vielzahl von Krankheiten in Verbindung gebracht, darunter vermeidbare 
Blindheit (Trachom) und reaktive Arthritis. Zudem ist es der häufigste bakterielle Auslöser 
sexuell übertragener Krankheiten, mit  für Frauen häufig fatalen Folgen wie 
Eileiterentzündung, Extrauterinschwangerschaft und Sterilität. Als obligat intrazelluläres 
Pathogen hängt Chlamydia trachomatis in nahezu allen Aspekten seines Überlebens von der 
Wirtszelle ab, angefangen bei der Anheftung an die Wirtszelle, über die Invasion, der 
Aufnahme von Wirtszellmetaboliten bis zur intrazellulären Replikation. Intrazelluläre 
Interaktionen zwischen Wirt und Pathogen spielen bei der erfolgreichen Chlamydien-
Infektion eine entscheidende Rolle. Trotz der weiten Verbreitung und der immensen 
Bedeutung bei verschiedenen Krankheiten ist wenig über die dem Infektionsprozess und den 
der Chlamydien-Replikation zugrundeliegenden Mechanismen bekannt. Für ein vollständiges 
Bild der Pathogenese sind sowohl das Verstehen der dazu beitragenden bakteriellen wie 
auch Wirtszellfaktoren essenziell. Die vorliegende Arbeit konzentriert sich dabei auf die an 
der Infektion beteiligten Wirtsfaktoren. Für derartige Studien hat sich das Ausschalten von 
Genfunktionen mittels RNA-Interferenz als ein robustes und zielgerichtetes Werkzeug 
herausgestellt. Sie ist die Methode der Wahl für sogenannte Funktionsverluststudien (loss-
of-function studies) und kann dazu dienen, den Beitrag der Wirtszelle an der Chlamydien-
induzierten Pathogenese aufzuklären. 
 
Um tiefere Einblicke in die Abläufe chlamydialer Infektionen zu erlangen, wurde in dieser 
Arbeit ein RNA-Interferenz-vermittelter Funktionsverlustscreen durchgeführt. Als Indikator 
für Effekte auf die primäre Infektion wurde die Anzahl chlamydialer Inklusionen sowie deren 
Größe bestimmt. Um Aufschlüsse über den Einfluss von Wirtszellfaktoren für den 
kompletten Durchlauf des bakteriellen Lebenszyklus zu erlangen wurde zudem die 
Chlamydien-Vermehrung quantifiziert. In diesem Rahmen wurden 1500 humane Gene, die 
unter anderem das gesamte humane Kinom, sowie für Apoptose und für den intrazellulären 
Transport relevante Gene umfassten, durchmustert. Mithilfe verschiedener statistischer 
Methoden wurden 132 primäre Hits selektioniert. Um mögliche, bei der RNA-Interferenz 
auftretende, zielgenunabhängige Effekte auszuschließen, die zu falsch-positiven Hits führen 
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können, wurden die primären Hits mit vier weiteren siRNAs validiert. Damit gelang die 
Identifizierung von 59, für die Chlamydien-Infektion und Vermehrung relevanten Genen. 
 
Unter Zuhilfenahme von bioinformatischen Signaltransduktionsweganalyse-programmen 
konnten einige der Hits bekannten zellulären Signalnetzwerken, unter anderem dem 
Ras/Raf/Mek/Erk-Signalweg, zugeordnet werden. Insbesondere der Funktionsverlust zweier 
validierter Targets, Ras und Raf1, erhöhte das Chlamydien-Wachstum und deren 
Vermehrung. Aufgrund vorheriger in der Literatur beschriebenen Studien wurde bisher 
angenommen, dass die bei der Chlamydien-Infektion beobachtete Aktivierung der Kinase 
Erk, die mit der Aktivierung der Phospholipase cPLA2, der Induktion des Interleukins 8 sowie 
der Stabilisierung des antiapoptotischen Faktors Mcl-1 in Verbindung steht, über den 
Ras/Raf/Mek-Signalweg vermittelt wird. Ich konnte jedoch zeigen, dass die Chlamydien-
induzierte Erk-Aktivierung unabhängig von Ras und Raf1 stattfindet. Vielmehr wird während 
der Chlamydien-Infektion, Raf1, abhängig von der Kinase Akt, durch Phosphorylierung an 
Serin259 inaktiviert wird. Zudem wird das inaktivierte Raf1, wiederum abhängig von Akt und 
dem Adapterprotein 14-3-3β, zur bakteriellen Inklusion rekrutiert. Dies lässt vermuten, dass 
das Überleben derChlamydien und deren Wachstum nicht nur von der Erk-Aktivierung und 
dessen Substrate sondern auch von der Inaktivierung von Raf1 und dessen Rekrutierung zur 
Inklusion abhängt.  
 
Die vorliegende Arbeit liefert erhebliche Beiträge zum tieferen Verständnis zur Rolle von 
Wirtszellfaktoren bei Chlamydien-Infektionen. Mithilfe einer Funktionsverlust-
Hochdurchsatzanalyse konnte ich eine Vielzahl relevanter Gene identifizieren, die 
insbesondere für die spezifische Regulation von Wirtszellsignalwegen nötig sind, um die 
Entwicklung der Pathogene und ihr Überleben zu sichern. Die Erkenntnisse dieser Arbeit 
haben direkten Einfluss auf unser Verständnis von Bakterien-Wirtszellinteraktionen und 
können dazu beitragen bessere Behandlungsstrategien für Infektionskrankheiten zu 
entwickeln. 
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ABSTRACT 
Chlamydia trachomatis is a Gram-negative obligate intracellular bacterial pathogen. It is 
associated with significant human illness, including preventable blindness, reactive arthritis. 
Furthermore, it is the most common agent of bacterial sexually transmitted diseases with 
potentially serious sequel in women that include pelvic inflammatory disease, ectopic 
pregnancy and sterility. As an obligate intracellular pathogen, Chlamydia rely on host cell for 
all aspects of their survival, from the initial attachment with the host cell membranes, to 
cellular invasion, acquisition of host cell metabolites and intracellular replication. Unique and 
largely uncharacterized intracellular host-pathogen interactions are critical for successful 
chlamydial infection. Despite the prevalence of Chlamydia spp. and their role in human 
disease, little is known about the mechanisms underlying the infection process, the host 
pathogen interactions, and the intracellular survival and replication of Chlamydia. To gain a 
comprehensive understanding of the disease pathogenesis, it is equally important to 
understand the contribution of the host as well as the pathogen to these complex host 
pathogen interactions. Therefore in this study I decided to focus on the host factors involved 
in the Chlamydia infections. For this purpose, silencing of gene expression by RNA 
interference (RNAi) has proven to be a robust and straight forward technique for gene 
function analysis in eukaryotic cells. This has become a method of choice for loss of function 
studies and can serve to unravel the contribution of host cell in the pathogenesis during 
Chlamydia infection. 
 
This study aims to obtain deeper insights into infection processes of Chlamydia by using 
RNAi based loss-of-function screen of host cell determinants. As a readout Chlamydia 
number and inclusion size for the primary infection as well as quantification of Chlamydia 
progeny (infectivity) were measured to monitor entry, survival and replication of the 
pathogen within the host. Therefore, a screen was performed in 96 well format, analyzing 
the impact of ~1500 different human genes mainly covering the human kinome, apoptosis as 
well as trafficking related genes. With help of various robust statistical analysis methods 134 
primary hits were selected for further analysis. To rule out possible off-target effects, which 
are inherent to the current status of RNAi technology, the primary hits were further 
validated using 4 new siRNA sequences for each of the identified primary hits. This resulted 
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in the identification of 59 host cell genes influencing C. trachomatis infection and infectivity. 
Further analysis of the hits using pathway analysis tools revealed several prominent signaling 
networks, including Ras/Raf/Mek/Erk pathway. Among the identified targets, knockdown of 
Ras and Raf1 components of the aforesaid pathway led to increased chlamydial growth and 
survival. In Chlamydia infections, Erk activation which is believed to be activated through 
upstream kinases Ras/Raf/Mek is associated with activation of cPLA2, induction of IL8 and 
stabilization of the anti-apoptotic Bcl-2 family member Mcl-1. 
 
However, I could show that ERK activation after Chlamydia infection is independent of Ras 
and Raf1. Moreover, it is also evident that in infected cells Raf1 is inactivated by 
phosphorylation at Ser259 in an Akt dependent manner. Consequently, the Ser259 
phosphorylated Raf1 was recruited to the Chlamydia inclusion in an Akt and 14-3-3β 
dependent manner. This strongly suggests that Chlamydia survival and replication in the host 
cell depends not only on the activation of ERK and its downstream targets such as cPLA2, but 
also on the inactivation of Raf1 by phosphorylation and recruitment to the inclusion. The 
presented work applying RNAi based screening for the dissection of host cell factors involved 
in C.trachomatis infection gives considerable insights for a broader understanding of how 
Chlamydia can activate and deactivate specific host cell pathways for their own benefit. The 
findings of this study have direct implications in our understanding of the Chlamydia disease 
causing potential and its interactions with the host cells, which might help in evolving better 
treatment strategies. 
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1 Introduction 
1.1 Chlamydia 
Chlamydiales are obligate intracellular bacterial pathogens that can infect a broad range of 
host organisms. The earliest known descriptions of Chlamydia like diseases, resembling the 
symptoms of trachoma, are from ancient Chinese and Egyptian writings. However, 
Halberstädter and von Prowazek were the first to identify the responsible infectious species 
in 1907, which today is known as Chlamydia trachomatis (Ctr).  
Members of the order Chlamydiales are named after the greek word 'chlamys' meaning 
cloak, based on the incorrect assumption that these organisms are intracellular protozoan 
pathogens that appear to cloak the nucleus of host cells (Byrne, 2003). Today it is known 
that these pathogens are Gram-negative bacteria. The observed cloak is in fact the inclusion 
(Figure 1a) containing numerous individual bacteria. 
 
Figure 1: Electron microscopic images of Chlamydia trachomatis (a) Chlamydia trachomatis inclusions 1 day 
post infection in epithelial cells. (b) Elementary bodies (EBs, black arrow) and reticulate bodies (white arrows). 
Double arrow heads point to an intermediate body (IB) that started DNA decondensation. I=inclusion; 
IM=inclusion membrane. (Images kindly provided by Dr. H. Al-Younes, MPI for Infection Biology, Department of 
Molecular Biology, Berlin.) 
 
Chlamydia spp. have a biphasic developmental cycle, during which they are found in two 
forms; the metabolically inactive, but infectious extracellular form named elementary bodies 
(EBs) and the metabolically active, but non-infectious intracellular form, the reticulate 
bodies (RBs). The development and replication of Chlamydia occur inside host cells in a non-
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acidified vacuole termed as inclusion. In order to establish an intracellular niche inside 
eukaryotic hosts, Chlamydia have evolved or acquired capabilities to enter host cells, 
replicate inside a suitable environment, evade the immune system, and escape to re-initiate 
infections in other host cells. Unique and largely uncharacterized intracellular host-pathogen 
interactions seem to be critical for successful chlamydial infection. As an obligate 
intracellular pathogen, Chlamydiae rely on host cells for all aspects of their survival, from the 
initial attachment with the host cell membranes, to cellular invasion, acquisition of host cell 
metabolites and intracellular replication. 
 
1.1.1 Taxonomy 
Until the year 2000 the subdivision of the order Chlamydiales has been mostly based on 
pheno- and genotypic features (Kaltenboeck, et al., 1993). The only member of this order 
was the family Chlamydiaceae and two genera. The genus Chlamydia was separated into 
four different species, C. pecorum, C. pneumoniae, C. psittaci and C. trachomatis. In 2001 a 
new system of classification has been introduced, based on 16S rRNA and 23S rRNA 
sequence comparisons (Figure 2). The Chlamydiaceae are now divided based on these rRNA 
analyses (Bush and Everett, 2001). 
The family Chlamydiaceae is divided into two genera, Chlamydia and Chlamydophila. The 
genus Chlamydia includes the human pathogen C. trachomatis, the mouse pathogen C. 
muridarum, and the swine pathogen C. suis. The Chlamydophila genus is more diverse with 
six species, including important human pathogen C. pneumonia and animal pathogens such 
as C. psittaci, and C. caviae (Pudjiatmoko, et al., 1997; Takahashi, et al., 1997). Based on 16S 
rRNA sequence relatedness, three new families, Parachlamydiaceae, Simkaniaceae, and 
Waddliacea (Everett, et al., 1999; Rurangirwa, et al., 1999) were also included into the 
Chlamydia taxonomy. While these organisms are termed "environmental chlamydiae", some 
evidence suggests that they may also be associated with clinical disease in humans and 
animals (Lieberman, et al., 2002).  
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Figure 2: Schematic overview illustrating the new taxonomy of the order Chlamydiales 
 
1.1.2 Diseases caused by human pathogenic Chlamydia strains  
Biological differences (biovars) or serological differences (serovars) within C. trachomatis 
have led to sub classifications into biovars and serovars respectively. C. trachomatis can be 
separated into the biovars trachoma and the lymphogranuloma (LGV), which is based on 
clinical, experimental differences and their ability to infect tissue culture cells (Kuo, et al., 
1973; Kuo, et al., 1972). Based on serological identification, serovars or serological variants 
of trachoma and LGV are designated with letters and/or numbers.  
The trachoma biovar consist of 14 serovars such as A to K as well as Ba, Da, and Ia. The 
genital serovars (D, K) are the most common cause of sexually transmitted diseases 
(Gerbase, et al., 1998), while the ocular serovars (A, B, Ba or C) cause the blinding trachoma 
(Schachter, 1978). Infections by strains of the trachoma biovar are confined to mucosal 
epithelia, such as the urogenital tract or the conjunctiva (Schachter, 1978). They are 
associated with trachoma, an infection of conjunctival epithelia that, through persistence 
and re-infection, causes a chronic disease that leads to blindness. In developing countries, 
trachoma has an estimated annual incidence of 80 million cases with 6 million individuals 
blinded as a result of this disease (Thylefors, et al., 1995). An estimated 92 million adults 
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worldwide contract sexually transmitted chlamydial infection each year and are associated 
with 60% of tubal infertility cases and 40% of ectopic pregnancy cases (Peipert, 2003). 
Sexually transmitted C. trachomatis infection results in a variety of anomalies including 
mucopurulent cervicitis, urethritis, salpingitis, lymphogranuloma venereum, endometritis, 
opthalmia neonatorum, and infant pneumonia (Schachter, 1978). 
The LGV biovar consists of four serovars, L1, L2, L2a and L3, which can invade lymphatic 
tissue. LGV biovar infections originate at a mucosal site, but serious disease is associated 
with systemic dissemination and proliferation in cells of the lymph nodes (Schachter and 
Osoba, 1983). A recent work suggests that, previous infection of C. trachomatis increases the 
likelihood of HIV and/or HPV transmission, demonstrating that the chlamydial infections 
increase the risk of HIV transmission at least three- to five-fold (Nusbaum, et al., 2004).  
C. pneumoniae species were described as respiratory pathogens infecting many humans in 
all areas of the world (Kuo, et al., 1995). Epidemiological studies of C. pneumoniae have 
shown that the pathogen is very common worldwide with 60-70% of adults being 
seropositive. Transmission appears to be from person to person. The pathogen is a cause of 
a broad spectrum of respiratory tract infections with a tendency to become chronic and 
reinfection is a common event. The most serious outcome of respiratory tract infection is 
pneumonia. Clinical manifestations include a wide spectrum of diseases such as bronchitis, 
pneumonitis, sinusitis, and acute pharyngitis. Cases of primary infection are more severe and 
prolonged than those of reinfection. There is evidence that C. pneumoniae is responsible for 
atherosclerotic cardiovascular disease, asthma and sarcoidosis (Cochrane, et al., 2005; 
Cuffini, et al., 2006; Kalayoglu, et al., 2002).  
C. psittaci is widely distributed and affects many mammalian and avian species causing 
genital, intestinal, conjunctival, or respiratory infections. Genital infections with C. psittaci 
have been well characterized and can cause abortion and infertility. Although mammalian 
strains of C. psittaci are not known to infect humans, avian strains occasionally are known to 
cause infection in humans leading to pneumonia and the systemic illness known as 
psittacosis (Harkinezhad, et al., 2009). In general, chlamydial infection causes mild diseases 
with persistent infections and poor immunity.  
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1.1.3 The developmental cycle of Chlamydia 
The Chlamydia developmental cycle, as know today was first described by Bedson and Bland 
in 1932. It consists of two distinct morphological and functional forms, the elementary body 
(EB) and the reticulate body (RB). The developmental cycle occurs within a membrane-
bound vacuole, called "inclusion". The life cycle of Chlamydiae is a transition between EB 
into RB, RB into RB, and RB into EB (Figure 3Error! Reference source not found.).  
 
 
Figure 3: Schematic overview of Chlamydia life cycle. Chlamydiae have two developmental forms. The 
elementary body (EB), shown as red circles is infectious, metabolically inactive and small (0.2-0.3 μm). The 
reticulate body (RB) shown as green circles is larger (1.0 μm), non-infectious and metabolically active. The 
whole cycle takes between 24 – 72 h depending on species. 
 
The elementary body (EB) is a small (0.3 m), round, electron-dense, ‘spore-like’ 
metabolically inert but infectious form of the organism, whereas RB is larger (1 m) then EB, 
have less condensed structure, non-infectious and metabolically active (Matsumoto, 1973).  
1.1.3.1 Attachment and entry  
Chlamydiae are capable of attaching to and infecting non-phagocytic cells from various 
animal species. The attachment depends on polysaccharides and heparin sulphate (Spears 
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and Storz, 1979; Wuppermann, et al., 2001; Zhang and Stephens, 1992) by establishing 
strong bonds between host cells and bacteria (Duensing, et al., 1999).  
Chlamydiae have evolved extremely efficient means of invading nonphagocytic cells. For 
this, more specific interactions with so far unidentified host-receptors are thought to be 
involved (Dautry-Varsat, et al., 2005). After cell adhesion, the Chlamydiae are either 
endocytosed or phagocytosed, both clathrin-dependent and independent mechanisms are 
proposed (Dautry-Varsat, et al., 2005). Immediately after irreversible binding, type III 
secretion system (TTSS) exports Tarp protein (Translocated actin-recruiting phosphoprotein, 
CT456) into the host cell (Clifton, et al., 2004). Where it is phosphorylated at tyrosine 
residues, this leads to remodelling of the cytoskeleton (Clifton, et al., 2004). All these 
findings show that chlamydial EBs contain functional TTSS that is capable of delivering 
signals inside the host cell prior to differentiation into RB. Assembly of TTSS into functional 
complexes and expression of early effector molecules such as Tarp may be accomplished 
during redifferentiation of RB into EB. This may furnish metabolically inert EBs with 
molecules that are active upon EB attachment and important for invasion into the host cell. 
The key question which still remains elusive is the identification of chlamydial ligands 
responsible for the attachment to host cells. Several chlamydial proteins are exposed at the 
surface and that makes them potential candidates for the role of adhesin proteins. Among 
these proteins are OmcB, OmpA and HSP70 (MOMP). Pmp proteins are also suggested to be 
involved in attachment (Everett and Hatch, 1995; Grimwood, et al., 2001; Grimwood and 
Stephens, 1999). Several important signal transduction pathways are also known to be 
involved during the entry of Chlamydia in to the host cells, such as small GTPases (Rho, Rac, 
Cdc42, Arf6), PI3- kinases or MEK/ERK (Dautry-Varsat, et al., 2005) leading to host 
cytoskeleton rearrangements, thus facilitating the pathogen entry.  
 
1.1.3.2 Intracellular development  
For any intracellular pathogen the development inside a host cell is a significant challenge. 
However, for this purpose intracellular parasites have evolved various strategies to escape 
lysosomal killing. One of the key routes for surviving is by occupying distinct compartments 
within the host cell. Pathogens like Shigella, Listeria or Rickettsia replicate in the cytoplasm 
(Hackstadt, 1996; Hackstadt, 1998; Marquis, et al., 1997). Others like Leishmania or Coxiella 
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even survive harsh acidic conditions inside the lysosome, which are even supportive for their 
own metabolism (Hackstadt and Williams, 1981; Mukkada, et al., 1985). Chlamydia is a 
member of another group of intracellular parasites that reside in a unique vesicle which does 
not fuse with lysosomes. For most cases, the biogenesis of these vacuoles is not well 
understood. This strategy of forming non- lysosomal vacuoles for surviving inside host 
organisms is another survival technique used by many intracellular parasites such as the 
bacteria M. tuberculosis, M. avium, L. pneumophila, S. typhimurium and Chlamydia as well 
as the protozoan Toxoplasma gondii (Garcia-del Portillo and Finlay, 1995; Rikihisa, 1991; 
Wells and Rikihisa, 1988).  
Another specific feature of the chlamydial inclusion is the lack of acidification which would 
prevent the optimal activity of acid hydrolases. It was demonstrated that, in cells that 
phagocytose both yeast and Chlamydiae, the vacuoles containing Chlamydia are protected 
from phagolysosomal fusion (Eissenberg and Wyrick, 1981). It was also revealed that early 
inclusions with EB are prevented from maturation into phagolysosomes (Eissenberg, et al., 
1983) and inhibition of chlamydial protein synthesis leads to fusion with lysosomes 
(Scidmore, et al., 1996).  
During the first four hours after Chlamydia entry into the host cells many events occur. At 
first, the EB endosome pH drops to 6.2 and then stabilizes at 6.6, the initial drop in pH may 
be required for the recycling of the receptor(s) to the cell surface in addition might play a 
role in catalyzing the conversion of metabolically inactive EB to metabolically active RB and 
the later stabilization of the pH at 6.6 might help Chlamydia to avoid lysosomal fusion 
(Schramm, et al., 1996). The endosome containing EB escapes fusion with lysosomes, within 
two hours after infection the EB-containing vesicle is devoid of markers that distinguish early 
and late endosomes or lysosomes. Phosphorylation of epithelial proteins triggered by the EB 
attachment results in rearrangement of the host cell cytoskeleton (Birkelund, et al., 1994; 
Fawaz, et al., 1997). Local accumulation of F-actin and clathrin helps to redistribute 
endosome containing EB to the perinuclear region (Majeed and Kihlstrom, 1991). This 
translocation depends on dynein motor driven movement of the EB vacuoles on 
microtubules (Clausen, et al., 1997; Schramm and Wyrick, 1995). It was also discovered that, 
if the intracellular concentration of calcium remains at homeostatic level, EB-containing 
endosomes can fuse with one another, but not with lysosomes (Majeed, et al., 1994). Early 
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Chlamydia gene expression leads to vacuole modification and subversion of the EB 
trafficking from the endocytic to the exocytic pathway. 
Approximately six hours after internalization, the transition of EBs into RBs is complete and 
metabolically active RBs enter the logarithmic growth stage, with a generation time of 2-2.5 
hours, which continues until 24-40 hours after infection. Very little is known about the 
function and composition of the inclusion membrane that forms the Chlamydia inclusion. As 
bacteria grow and proceed through their developmental cycle, the inclusion also grows and 
expands. This process is not dependent on host protein synthesis because the chlamydial 
inclusion develops normally in cells treated with the inhibitor cycloheximide. The inclusion 
can intercept vesicles released from the Golgi apparatus thereby capturing mostly 
sphingolipids, phospholipids and cholesterol (Hackstadt, et al., 1997; Scidmore, et al., 1996). 
Activation of cPLA2 through Mek/Erk signaling pathway was shown to be essential for 
chlamydial acquisition of host glycerophospholipids (Su, et al., 2004). Recently it was also 
shown that Chlamydia induces fragmentation of Golgi apparatus to form ministacks for 
efficient acquisition of lipids (Heuer, et al., 2009). Other nutrients such as amino acids 
(Hatch, 1975; Karayiannis and Hobson, 1981), Nucleotides (McClarty and Qin, 1993) or iron 
(Al-Younes, et al., 2001) need to be recruited from the host cell as well. 
In addition to the re-routing of endosomal traffic, intracellular Chlamydiae also disturb other 
cellular functions: N-cadherin dependent cell-cell junctions are disrupted and apoptosis is 
inhibited (Greene, et al., 2004; Rajalingam, et al., 2001). The MHC Class I and Class II 
response is also disturbed through the secretion of a protease which cleaves transcription 
factors of MHC antigens (Heuer, et al., 2003; Zhong, et al., 2001). 
 
1.1.3.3 Persistence 
As an interruption of the classic lifecycle, persistent infections can occur, which are induced 
by external stimuli. During persistence, RBs do not redifferentiate into EBs, but develop into 
so called aberrant bodies (Abs) with significantly modified morphology (de la Maza, et al., 
1987). The bacteria stay metabolically active but are unable to establish a productive 
infection. By this means, Chlamydiae are inaccessible to the host’s immune system and can 
survive for a long period of time. If the stimulus is removed, the bacteria are reactivated and 
continue to undergo the regular, acute developmental cycle. 
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1.1.3.4 Exit from the host cell  
Escape into the environment is the final step of the chlamydial life cycle. Despite the 
apparent simplicity of the exiting process, the real mechanisms that direct the end of the 
developmental cycle and trigger transition of RB back to infectious EB are almost completely 
unknown. This process may involve multiple events. A decrease in host nutrients may signal 
detachment of RB from the inclusion membrane and activation of histone proteins. Histone 
proteins can regulate stage-specific expression of genes and initiate DNA condensation 
(Barry, et al., 1992; Tao, et al., 1991).  
The fact that different species of Chlamydiae exit host cells in different ways supports active 
and complex processes behind this final stage of the developmental cycle. Some Chlamydiae 
lyse the host cell when exiting, whereas others exit in a less aggressive manner. For example, 
C. trachomatis serovar D (UW3 isolate) exit cells by exocytosis. The inclusion moves along 
the exocytic pathway to the epithelial surface for fusion with the plasma membrane. During 
this process the inclusion exvaginates at the plasma membrane and the host cell remains 
viable (Todd and Caldwell, 1985). Other serovars of C. trachomatis, such as LGV strains, 
destroy the host cell when exiting. It was reported that Chlamydiae encode a cytotoxin with 
a unknown role (Belland, et al., 2001). It is possible that this toxin is involved in the process 
of releasing bacteria from the cell.  
 
1.2 RNA interference 
A turning point for large-scale functional studies in animals was the discovery that long 
double-stranded (ds)RNA triggers potent and specific mRNA degradation in C. elegans 
through the evolutionarily conserved RNA interference (RNAi) process (Figure 4) (Fire, et al., 
1998).  
Because long dsRNA can be easily and reproducibly synthesized and introduced into C. 
elegans RNAi became soon a standard method and expanded rapidly from single-gene to full 
genome functional studies in this model organism (Fraser, et al., 2000; Gonczy, et al., 2000; 
Kamath, et al., 2003). While this approach has been successful in model organisms such as D. 
melanogaster (Kennerdell and Carthew, 1998), the use of long dsRNAs for RNAi in most 
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mammalian cells was hampered by the induction of a strong, non-specific interferon 
response by dsRNAs longer than 30 bp (Stark, et al., 1998). 
The analysis of the molecular mechanism of RNAi revealed that long dsRNA is cleaved by the 
RNase III-like enzyme Dicer into 21-23 nt short interfering (si)RNAs, which are the ultimate 
mediators of RNAi (Elbashir, et al., 2001). Further analyses revealed that siRNAs are targeted 
to the RNA induced silencing complex (RISC) (Martinez, et al., 2002), where they are 
unwound by the Argonaute2 protein (Meister, et al., 2004). If the antisense strand is loaded 
into RISC it triggers degradation of (partially) complementary mRNA. Thus, siRNAs elicit 
mRNA degradation without inducing the interferon pathway and have therefore enabled the 
use of RNAi as a functional genomic tool in mammals.  
For mammalian RNAi experiments a range of technologies that closely mimics the 
endogenous Dicer cleavage products has been developed. Today, the most commonly used 
approaches are chemically synthesized siRNAs (Elbashir, et al., 2001), which were historically 
the first RNAi reagents introduced for mammalian tissue culture cells and vector-expressed 
short hairpin (sh)RNAs that are converted intracellularly into siRNAs (Brummelkamp, et al., 
2002).  
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Figure 4: Overview of mechanism of RNA interference 
 
Several large-scale libraries for the human and mouse genomes have been recently 
generated with these two technologies and have been made available through a number of 
suppliers (Echeverri and Perrimon, 2006). Both, siRNA and shRNA libraries require the 
synthesis of either RNA or DNA oligonucleotides that are transfected directly or first cloned 
into an expression vector, respectively.  
Both approaches have advantages and disadvantages depending on the experimental 
context and the price aspect (Echeverri and Perrimon, 2006). An important requirement for 
any large-scale RNAi study is a high knockdown efficiency for each individual silencing trigger 
in a library. For this purpose, the most recently released siRNA and shRNA libraries have 
used design algorithms that are based on thermodynamic and sequence-specific properties 
to predict efficient silencing molecules (Boese, et al., 2005; Silva, et al., 2005). While the use 
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of these algorithms has improved the overall silencing efficacy, no prediction algorithm 
exists yet that can exclude off-target gene silencing, which has been recently recognized as a 
major challenge for the reliability of data generated in screen using siRNAs or shRNAs 
(Jackson, et al., 2003; Lin, et al., 2005). Detailed analyses revealed that siRNAs and shRNAs in 
addition to their specific targets down regulate numerous unintended transcripts with 
limited sequence complementarity to the specific siRNA target sequence (Birmingham, et al., 
2006; Jackson, et al., 2006), which makes the design of fully specific silencing molecules 
difficult if not impossible.  
 
1.2.1 Functional RNAi screening applied to study host pathogen interactions 
The use of RNA interference (RNAi) to rapidly and efficiently inhibit the expression of 
proteins (Bass, 2000) offers the possibility of carrying out unbiased reverse genetic screens 
to identify host proteins critical in microbial pathogenesis. Several screens have already shed 
light on various cellular processes such as cell viability (Boutros, et al., 2004), cytokinesis 
(Eggert, et al., 2004), wnt Signaling (DasGupta, et al., 2005), JAK/STAT Signaling (Baeg, et al., 
2005), and mechanisms of host–pathogen interaction, including Listeria and Mycobacterium 
pathogenesis (Agaisse, et al., 2005; Cheng, et al., 2005; Philips, et al., 2005), Candida albicans 
phagocytosis (Stroschein-Stevenson, et al., 2006), L. pneumophila exploitation of the early 
secretory pathway (Dorer, et al., 2006) and involvement of PDGFR, Abl kinases (Elwell, et al., 
2008) as well as Tom complex (Derre, et al., 2007) for C. trachomatis infection. Most of the 
above mentioned screens were done using the D. melanogaster cells.  
In this study we established and performed an RNAi based screen in human cells for the first 
time to study C. trachomatis and host cell interactions. 
 
1.3 Ras/Raf/Mek/Erk Signaling cascade 
The Ras/Raf/MEK/ERK (Figure 5Error! Reference source not found.) signaling was the first 
MAP kinase cascade to be characterized. It is probably one of the most well known signal 
transduction pathways among biologists because of its implication in a wide variety of 
cellular functions as diverse -and occasionally contradictory- as cell proliferation, cell-cycle 
arrest, terminal differentiation and apoptosis. The initial step of the Raf/MEK/ERK cascade is 
22 
the activation of Raf1 by direct interaction with a GTP-Ras protein (McCubrey, et al., 2007). 
The GTP-bound active Ras can recruit Raf1 to the cell membrane by binding to the Ras-
binding domain of Raf1 (C-Raf). Once at the cell membrane Raf1 can be activated by multiple 
phosphorylations on serine, threonine, and tyrosine residues (Morrison and Cutler, 1997). 
Even though the exact mechanism of Raf1 activation is still a matter of controversy it can be 
summarized in a following way based on the existing knowledge. Amino-terminal part of 
Raf1 is shown to be involved in negative regulation of its enzymatic activity as its truncation 
results in constitutive activation of the kinase activity (Morrison and Cutler, 1997). 
Phosphorylation of Tyr340 and Tyr341 sites are important for Raf1 activation by both 
receptor and non-receptor tyrosine kinases (Marais, et al., 1995; Stokoe and McCormick, 
1997). Also Ser338 and Ser339 of Raf1 can be phosphorylated, and mutation of these 
residues partially blocks activation of Raf1 (Diaz, et al., 1997).In contrast to this, 
phosphorylation of Raf1 at Ser259 has an inhibitory effect. When phosphorylated, Ser259 of 
Raf1 becomes a binding site for the 14-3-3 protein (Muslin, et al., 1996), a negative regulator 
of Raf1. This residue may play a negative regulatory role, because its mutation to alanine 
results in an active kinase (Rommel, et al., 1997). So far exact mechanism through which 14-
3-3 binding inhibits Raf1 is ambiguous. While some models suggest that 14-3-3 binding may 
hold Raf1 in an inactive conformation, the others suggest that 14-3-3 could mediate 
interaction between Raf1 and a tyrosine phosphatase that dephosphorylates Tyr340 and 
Tyr341 tyrosines (Xia, et al., 1999). Raf1 also contains a second 14-3-3 binding site at Ser621, 
which has been shown to have a positive regulatory effect on Raf1 signaling (Ferrier, et al., 
1997). Taken together, 14-3-3 appears to have both positive and negative effects on Raf1 
signaling, depending on cell type and assay conditions (Morrison and Cutler, 1997). 
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Figure 5: Overview of Ras/Raf/MEK/ERK pathway. This figure illustrates how the Raf/MEK/ERK pathway is 
regulated by Ras as well as various kinases, which serve to phosphorylate S/T and Y residues on Raf. Some of 
these phosphorylation events serve to enhance Raf activity, whereas others serve to inhibit Raf activity 
Moreover, there are phosphatases such as PP2A, which remove phosphates on certain regulatory residues. 
Activated ERK can enter the nucleus and phosphorylate transcription factors or activate its substrates in the 
cytosol. Adopted from (Kolch, et al., 2002). 
 
Upon activation by kinases (e.g PAK, Src family kinases, and potentially PKC) Raf1 then 
phosphorylates mitogen-activated protein kinase (MEK) 1 and 2, which are dual specificity 
protein kinases that target tyrosine and serine/threonine residues for phosphorylation. All 
three Raf family members are able to phosphorylate and activate MEK with different 
biochemical potencies (Alessi, et al., 1994). (Figure 5) The predominant downstream target 
of MEK1/MEK2 is ERK (McCubrey, et al., 2007) a serine/threonine kinase existing in two 
isoforms ERK1 and ERK 2. The activities of ERK1 and ERK2 are positively regulated by 
phosphorylation of both T202 and T204 in the activation loop mediated by MEK1 and MEK2 
(McCubrey, et al., 2006). ERK can directly phosphorylate many transcription factors including 
Ets-1, c-Jun, c-Myc, S6 kinase (p90Rsk), and NFkB (Chang, et al., 2003; Nakano, et al., 1998) 
and is also known to phosphorylate cPLA2 (Hiller and Sundler, 1999). 
There are various studies demonstrating that the Chlamydia infection leads to activation of 
Erk followed by the down-stream activation of cPLA2 (Su, et al., 2004), an induction of IL8 
(Buchholz and Stephens, 2008), TnfR1 shedding (Paland, et al., 2008) and stabilization of 
Mcl-1 (Rajalingam, et al., 2008). 
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2 Aim of the study 
Chlamydia trachomatis is a Gram-negative obligate intracellular bacterial pathogen and is 
the cause of significant human illness, including preventable blindness, reactive arthritis. 
Furthermore it is the most common agent of bacterial sexually transmitted diseases with 
potentially serious sequel in women that include pelvic inflammatory disease, ectopic 
pregnancy and sterility. Chlamydia spp. have a biphasic developmental cycle, during which 
they are found in two forms; the metabolically inactive, but infectious extracellular form 
named elementary bodies (EBs) and the metabolically active, but non-infectious intracellular 
form, the reticulate bodies (RBs). The development and replication of Chlamydia occur inside 
host cells in a non-acidified vacuole termed as inclusion. In order to establish an intracellular 
niche inside eukaryotic hosts, Chlamydia have evolved or acquired capabilities to enter host 
cells, replicate inside a suitable environment, evade the immune system, and escape to re-
initiate infections in other host cells. Unique and largely uncharacterized intracellular host-
pathogen interactions seem to be critical for successful chlamydial infection. As an obligate 
intracellular pathogen, Chlamydiae rely on host cells for all aspects of their survival, from the 
initial attachment with the host cell membranes, to cellular invasion, acquisition of host cell 
metabolites and intracellular replication. 
Despite the prevalence of Chlamydia spp. and their role in human disease, little is known 
about the mechanisms underlying the infection process, the host pathogen interactions, and 
the intracellular survival and replication of Chlamydia. In spite of intense research genetic 
manipulation of Chlamydiae still remains impossible. Even though several options for 
generating a universal genetic system are currently being pursued, the anticipated success of 
these approaches is uncertain. On the other hand, silencing of gene expression by RNA 
interference (RNAi) has proven to be a robust and straight forward technique for gene 
function analysis in eukaryotic cells and has become a method of choice for loss of function 
studies. This affords the opportunity to uncover the novel host-pathogen interactions in 
cellular systems. In the past few years several RNA interference screens have been 
performed to study of host pathogen interactions including Listeria and Mycobacterium 
pathogenesis, Candida albicans phagocytosis as well as the L. pneumophila exploitation of 
the early secretory pathway. 
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In order to obtain a comprehensive insight in infection processes of Chlamydia, we decided 
to perform a loss-of-function screen of host cell determinants using high-throughput RNA 
interference. As readout we chose Chlamydia number and inclusion size for the primary 
infection, which would give us insights in to the pathogens entry and Chlamydia infective 
progeny (infectivity) to measure the survival and replication of the pathogen within the host. 
Therefore, the goal was to perform a screen in 96 well format, analyzing the impact of ~1500 
different human genes mainly covering the human kinome, apoptosis as well as trafficking 
related genes. Through this approach we aimed to identify host cell determinants, which 
influence Chlamydia entry and survival and replication with in host cells. The targets thus 
obtained were to be used for extensive functional analysis to determine the molecular 
mechanisms underlying the observed phenotypes and to identify the host cell processes 
exploited by Chlamydia. 
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3 Results 
3.1 Assay development and optimization of parameters  
Performing a successful high throughput RNAi screen needs a robust and specific assay. 
Developing an assay requires careful attention to every minor parameter. Also consideration 
has to be paid for establishing all the parameters with a thought for possible variations that 
can have a direct or indirect influence on the assay results. The assay specifically designed 
for studying Chlamydia infection and infectivity involve multiple parameters with several 
liquid handling steps. Therefore, all parameters of the assay should work synergistically 
introducing least possible variations due to handling. The following section of the results 
gives an overview of the assay and describes the optimization of each parameter in the 
development of this assay. 
 
3.1.1 Overview of the Chlamydia Infectivity Assay 
The general scheme of the assay which was developed hitherto is shown in Figure 6Error! 
Reference source not found.. The assay was aimed to identify host cell factors relevant for 
Chlamydia trachomatis infection and completion of the life cycle. For this we have set up a 
tripartite functional assay (Figure 6). At day 1 HeLa cells were transfected with the same 
siRNAs on three plates. The first plate was fixed 3 days post transfection to monitor the 
effect of the gene knockdown on the cell number. At the same day, the two other plates 
were infected with C. trachomatis, one of which was used to analyze the effect of gene 
knockdown (KD) on the primary infection. The third plate was lysed 48 hours post infection 
(hpi) and dilutions were used to infect non-transfected HeLa cells to identify genes required 
for the completion of C. trachomatis life cycle. After fixation, cells were stained with Hoechst 
dye for counting cell numbers and with an antibody directed against the major outer 
membrane protein (MOMP) of C. trachomatis. Nuclei and Chlamydia inclusions were 
acquired by automated microscopy and images were analyzed using an automated image 
analysis software (Scan^R, Olympus). As the main parameters, the number of inclusions per 
cell, and the inclusion size have been determined.  
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Figure 6: Infectivity assay overview. HeLa cells were seeded (1) and transfected (2) in triplicate plates. 72h post 
transfection (pt) one plate was fixed (3) to control for siRNA specific effects on cell growth. The remaining two 
plates were infected with Ctr (4) and 24h post infection (pi) one of the infected plates was fixed to evaluate the 
number and size of Ctr infectious particles (infection) (5). Fresh cells were seeded (6) and infected with the 
lysate from the remaining infected plate 48h post infection (7+8). The reinfected plate was fixed 24h post 
reinfection (9) for evaluation of the Ctr infectious progeny (infectivity). All plates were stained for host nuclei 
and with a Ctr specific antibody (10), images were acquired using automated microscopy (11), analyzed and the 
data exported for further analysis (12+13). 
 
3.1.2 Image acquisition and analysis  
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An important step in large scale screening is the automation image acquisition and analysis. 
Since such a large scale screen produces thousands of images to be analyzed to extract 
various parameters, based on which the hits will be identified. Therefore, it is imperative to 
automate this critical step of the screen. We used Scan^R automated microscopy system 
from Olympus for the acquisition of images. The screening plates generated were stained 
with Hoechst dye for counting cell numbers and with an antibody directed against the major 
outer membrane protein of C. trachomatis using the staining protocol described in 5.2.6. 
Throughout the screen 4 images/well were acquired for host nuclei in Hoechst channel and 
for Chlamydia inclusions in Cy3 channel shown in blue and red respectively in Figure 7Error! 
Reference source not found.. Subsequently we developed a custom analysis method using 
the Scan^R analysis software from Olympus. Analysis was based on gating the populations 
using the fluorescence, size, form and intensity parameters in the respective channels for 
nuclei and Chlamydia inclusions. The data extracted for various parameters such as number 
of objects, size and intensities etc were then exported for further analysis. 
 
 
Figure 7: Overview of the image analysis with Scan R analysis software. Example of the image analysis with the 
different parameters marked on the microscopic image, shown in red (Chlamydia inclusions) and blue (Nuclei). 
The parameters used for the gating, classification of both Chlamydia inclusions and nuclei are shown in the 
right panel. 
 
3.1.3 Optimizing Chlamydia infection conditions  
To establish Chlamydia infection in 96 well plates and also to adopt an optimal infection 
procedure, following infection conditions were tested. Volume of the infection medium, 
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washing the cells with phosphate buffered saline after 2 hpi before replacing with fresh 
medium, replacing the medium without washing 2 hpi, no medium replacement as well as 
shaking and no shaking of the plates during the first 2 hours of infection (Figure 8). For this 
HeLa cells seeded at a density of 8000 cells/well 1 day before were infected with an MOI 0.5 
of C. trachomatis. Elementary body’s were resuspended either in 100 µl or 50 µl of infection 
medium and added to the cells in 96 well plates after removing the medium. The plates were 
subjected to shaking every 30 minutes or left without during first 2 hours of infection. 
 
 
Figure 8: Optimizing Infection of C. trachomatis in 96 well plates. C. trachomatis resuspended in either 100 µl or 
50 µl of infection medium were used to infect HeLa cells at an MOI of 0.5 in 96 well plates. During the first 2 
hours of infection plates were subjected to shaking (gray bars) or left without (black bars) every 30 minutes. 
Additional infection conditions were tested as indicated in the figure. Images were acquired and analyzed to 
determine % infection. The results represent means ± SD from three independent experiments. 
 
Additionally after the first 2 h of infection cells were treated differently, i.e. Chlamydia were 
left on the cells without medium replacement, cells were washed with PBS once and 100 µl 
of fresh infection medium added for the rest of the infection duration, or medium was 
replaced with 100 µl of fresh infection medium without washing the cells 2 h post infection. 
24 h later cells were fixed and were stained with Hoechst dye for counting cell numbers and 
with an antibody directed against the major outer membrane protein (MOMP) of C. 
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trachomatis. Nuclei and Chlamydia inclusions were acquired by automated microscopy and 
images were analyzed using the Scan^R software and % infection was calculated. 
It was found that shaking the plates and the volumes of the infection medium used for 
resuspending the EB’s did not have any influence on the rate of infection. Conversely leaving 
Chlamydia on the cells without medium replacement 2 h post infection resulted in slightly 
higher infection rate which could be attributed to development of secondary inclusions as a 
result of asynchronous infection, which we wanted to avoid for the screen to keep the 
conditions uniform. Also between the conditions of washing the cells or just a medium 
replacement without washing no difference could be detected, although infection with 50 µl 
infection medium resulted in slightly better infection rate. Finally I decided to use the 
condition where cells were infected with EB’s resuspended in 50 µl of infection medium, 
which was replaced with 100 µl of fresh infection medium 2 h post infection without 
washing the cells. 
 
3.1.4 Optimizing detergent concentration for cell lysis 
It was necessary to design a method for cell lysis, which would lead to complete lysis of the 
C. trachomatis infected cells and does not have an effect on the target cells on to which the 
supernatant is passaged. As the screen was intended to be performed in 96 well plates, it 
was not possible to use the conventional method of cell lysis using glass beads commonly 
used by the Chlamydia researchers. Therefore I tested two different detergents a non-ionic 
Nonidet P40 and a zwitterionic detergent CHAPS at final concentrations ranging from 0.01 to 
0.1% (Figure 9Error! Reference source not found.). HeLa cells plated at a density of 8000 
cells/well were infected with C. trachomatis at an MOI 0.5 in 96 well plates. 48 hpi cells were 
lysed with 0.1, 0.06, 0.03 and 0.01% final concentrations of either Nonidet P40 or Chaps 
detergents, serial dilutions of the lysates were used to infect cells seeded one day before. 24 
h later cells were fixed were stained with Hoechst dye for counting cell numbers and with an 
antibody directed against the MOMP protein of C. trachomatis. Nuclei and Chlamydia 
inclusions were acquired by automated microscopy and images were analyzed using the 
Scan^R software and the % infection was calculated. Nonidet P40 at a final concentration of 
0.06% was found to be most effective in complete lysis of the cells. It also did not affect the 
cell viability of the target cells in the infectivity plates. This was determined by counting the 
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cell numbers of the target cells of the infectivity plate. Therefore this concentration of the 
detergent was chosen for further experiments and the screen. 
 
 
Figure 9: Optimizing detergent concentration for cell lysis in infectivity plates. HeLa cells were infected with C. 
trachomatis with MOI 0.5 in 96 well plates. 48 hpi cells were lysed with the indicated final concentrations of 
either Nonidet P40 (black bars) or Chaps (grey bars) detergents and the lysates were used to infect freshly 
seeded cells. 24 h later cells were fixed and stained with antibody specific to C. trachomatis MOMP and 
Hoechst 33342. The results represent means ± SD from three independent experiments. 
 
3.1.5 Finding activating and inhibitory controls 
Appropriate controls are essential in the design of large scale experiments. Activating and 
inhibitory controls should be selected to develop a screen assay, as controls give important 
information on the reproducibility, robustness and ease of the assay.  
To find appropriate activating and inhibitory controls we tested siRNA’s targeting 10 
different genes (Figure 10 a and b) for some of which we had previously observed an 
influence on Chlamydia infectivity. Also for some of the genes more than one siRNA was 
tested, which are indicated by number followed by gene name (Figure 10 Error! Reference 
source not found.a and b).  
1500 HeLa cells/well were plated with 100 µl of growth medium (GM) in a 96 well plate 24 h 
before were transfected with the indicated siRNA’s (Figure 10 a and b). 3 days post 
transfection cells were infected with MOI 0.5 of C. trachomatis. The first plate was fixed 24 
hpi to analyze the primary infection. The other plate was lysed 48 h after infection and 
dilutions were used to infect non-transfected HeLa cells to determine the infectivity. After 
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fixation, cells were stained with Hoechst dye for counting cell numbers and with an antibody 
directed against the MOMP protein of C. trachomatis. Shown are the inclusion/nuclei of 
primary infection (Figure 10 a) and infectivity (Figure 10 b). As neutral control transfection, a 
siRNA for F-Luciferase was used as it does not target any gene in the genome. 
Knock down of Arf1, p115 and giantin led to increase in infectivity, small GTPase Arf1 KD 
resulted in the similar phenotype for all three siRNA sequences tested with least standard 
deviation (SD). Knock down of MAP1LC3A, MAP1LC3B, MAP1LC3A+B, CD71, Abi1 and Abi2 
led to decrease in infectivity, KD of MAP1LC3A+B together resulted in almost complete 
decrease with least SD. 
As shown in Figure 10 c and d, Arf1 knockdown leads to bigger inclusions as well as to a 
higher number of progeny. In contrast to this, MAP1LC3A/B knockdown results in smaller 
inclusions and almost no progeny. Automated image analysis of the primary infection, 
revealed that the inclusion size is increased by 81% upon Arf1 knockdown whereas it 
decreased after loss of MAP1LC3A/B by 41%. Furthermore, in re-infected plates 
quantification of inclusions per cell shows a 245% increase with siArf1 and an almost 
complete loss of re-infection after MAP1LC3A/B knockdown (Figure 10 c and d). These two 
controls not only show the functionality of our assay but also were used as activating and 
inhibitory controls throughout the siRNA screen.  
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Figure 10: Selection of controls for the assay. HeLa cells were transfected with the siRNAs targeting the 
indicated genes. For some genes more than one siRNA sequence was tested which are indicated with a number 
following the siRNA name. Three days post transfection cells were infected with C. trachomatis with MOI 0.5. 
Shown are the inclusions/nuclei of (a) primary infection and the (b) infective progeny for each siRNA tested. (c) 
siRNA targeting Luciferase (siLuci), Arf1 (siArf1), and Map1LC3 a +b (siLC3) were established as neutral, 
activating and inhibitory controls. Shown are representative images. (d) The calculated percentage of infection, 
inclusion size and infectivity for siArf1 and siLC3 normalized to siLuci. Shown is the mean ± SD of 3 independent 
experiments. 
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3.1.6 Optimizing Chlamydia multiplicity of infection 
Consequently the optimal multiplicity of infection (MOI) to distinguish changes both in 
primary infection and the infectivity phenotypes resulting from the KD of target genes was 
determined. HeLa cells seeded at a density of 1500 cells/well one day before were 
transfected with the control siRNAs identified in 3.1.5. 3 days post transfection cells were 
infected with C. trachomatis with MOI 0.25, 0.5, 0.75 or 1. The first plate was fixed 24 hpi to 
analyze the primary infection. The other plate was lysed 48 h after infection and dilutions 
were used to infect non-transfected HeLa cells to determine the infectivity. After fixation, 
cells were stained with Hoechst dye for counting cell numbers and with an antibody directed 
against the MOMP protein of C. trachomatis. 
 
 
Figure 11: Optimizing MOI of C. trachomatis for infectivity assay in 96 well plates. HeLa cells were transfected 
with the indicated siRNA and three days post transfection cells were infected with C. trachomatis with the 
indicated MOI. The primary infection as well as infectivity was measured. Shown are the Inclusions/nuclei for 
the primary infection (a) and the infectivity (b) for each MOI tested. The results represent means ± SD from 
three independent experiments. 
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Nuclei and Chlamydia inclusions were acquired by automated microscopy and images were 
analyzed using the Scan^R software. MOI of 0.5 showed primary infection rate between 25 
to 50% (Figure 11 Error! Reference source not found.a) and infectivity between 25 to 75% 
(Figure 11 Error! Reference source not found.b), with the reinfection rate of 50% for neutral 
control providing enough space to be able to distinguish increase and decrease of infectivity 
induced by KD of specific genes. The other MOI tested i.e. 0.25, 075 and 1 were either too 
low or too high. Consequently we decided to use MOI of 0.5 for the screen. 
 
3.1.7 Titration of cell number 
The starting cell numbers seeded for the assay would be equal irrespective of the siRNA to 
be transfected. However, siRNA transfection can induce cytotoxicity or cell proliferative 
effects to different extent depending on the targeted gene resulting in differences in the cell 
numbers between samples. Therefore it was essential to determine the range of cell 
numbers with in which the assay would work normally without having an influence on the 
infectivity outcome. For this purpose HeLa cells were seeded at different densities starting 
from 1000 to 64000 cells/well in 100 µl of growth medium in 96 well plates in duplicates 1 
day before infection. Cells were infected with same amount of C. trachomatis. The first plate 
was fixed 24 hpi to analyze the primary infection. The other plate was lysed 48 hpi and 
dilutions were used to infect non-transfected HeLa cells to determine the infectivity, which 
was also fixed 24 h post reinfection. After fixation, cells were stained with Hoechst dye for 
counting cell numbers and with an antibody directed against the MOMP protein of C. 
trachomatis. Nuclei and Chlamydia inclusions were acquired by automated microscopy and 
images were analyzed using the Scan^R software. Nuclei number and inclusion/nuclei of 
primary infection (Figure 12 a and c) as well as nuclei number and inclusion/nuclei of 
infective progeny (Figure 12 b and d) were determined. The results of the inclusion/nuclei of 
primary infection as well as infectivity show that the assay works well within the tested 
range of cell numbers without having a profound influence on the infective progeny (Figure 
12 d). However, very low as well as very high cell numbers can have an influence on the 
infectivity outcomes as the inclusion development can be different, with inclusion being 
bigger with low cell density and smaller with higher cell densities. Hence, we decided that in 
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the screen if the total cell numbers counted for each sample from 4 microscopic fields were 
less than 500 the result for that gene should not be considered for further evaluation. 
 
 
Figure 12: Titration of cell number. To determine the range of cell numbers within which the screen can be 
performed and to establish the right cell numbers for screen, HeLa cells were seeded in 96 well plates at 
different cell numbers and infected with same amount of C. trachomatis. The primary infection as well as 
infectivity was measured. Shown are the nuclei counts (a) and the inclusion/nuclei (c) of primary infection and 
nuclei counts (b) and inclusion/nuclei (d) of the infectivity plates respectively. The results represent means ± SD 
from three independent experiments. 
 
3.1.8 Automation of the assay  
Since the assay was eventually intended for high throughput screening, it was necessary to 
minimize the number of steps which require manual intervention. So the next step in the 
establishment of the assay was to automate the liquid handling steps for the process of 
transfection and infectivity. Initial cell seeding and the primary infection step of the assay 
were performed manually. For this purpose, a pipeting robot (BioRobot® 8000 system, 
Qiagen) was used.  
The process of transfection involves several steps, such as removal of medium from the cells, 
preparation of siRNA and HiperFect complexes in 96-well plates and pipetting the complexes 
37 
into the appropriate wells. The process of infectivity involves addition of Nonidet P40 to the 
cells, mixing of the detergent and the medium as well as shaking the plate to ensure 
effective cell lysis, performing serial dilution of the lysate and finally pipetting the 1:100 
diluted lysate into appropriate wells of the target plate after medium aspiration.  
 
 
 
Figure 13: Automation of the assay. HeLa cells were either transfected manually or using BioRobot® 8000 
system (Qiagen) with the siRNA targeting the indicated genes. Three days post transfection cells were infected 
with C. trachomatis with MOI 0.5. Following this cell lysis and reinfection was also either performed manually 
or using BioRobot® 8000 system (Qiagen). Shown are the inclusion/nuclei of the infectivity plates from manual 
(black bars) or automated (gray bars) protocols. The results represent means ± SD from three independent 
experiments. 
 
Because the assay was initially established manually, automation was optimized for each 
step separately, hence it was necessary to compare between the manual and automated 
assay before commencement of the screen. 
For this HeLa cells were transfected with siRNAs indicated in Figure 13 either manually or 
using the BioRobot® 8000 system (Qiagen). 3 days post transfection both were manually 
infected with C. trachomatis using automated multichannel pipette followed by infectivity 
performed 48 hpi again either manually or using the BioRobot® 8000 system (Qiagen). 
Although the observed inclusion/nuclei of the automated protocol (Figure 13 gray bars) 
were less than that of the manual protocol (Figure 13 black bars) for all the tested samples, 
the results displayed the same tendency in both. These results led us to conclude that the 
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automation of the assay to be successful and robotic protocols can thus be used for 
screening. 
 
3.2 The siRNA screen 
I screened three siRNA libraries: A kinase library targeting 646 kinases and kinase binding 
proteins, an apoptosis library directed against 418 apoptosis related genes and a custom 
library targeting 461 genes with a broad range of cellular functions. The kinase and the 
apoptosis library contained two siRNAs per gene which have been pooled into one well. For 
the custom library, if available, the two siRNAs also have been pooled into one well. During 
assay development, we observed that cells in the outer wells of a 96 well plate tended to 
accumulate at the outer edge of the plate resulting in unequal cell density compared to 
inner wells. Since infection efficiency might depend on the cell density, we omitted these 
wells from the screen. Thus, the screening plates contained siRNAs against 48 library genes 
and a quadruplicate of the three types of controls: siLuc (neutral), siMAPLC3A/B (inhibitory), 
and siArf1 (activating) (Figure 14Error! Reference source not found.). Each of the library 
plates was screened at least three times. Only plates where the controls showed increased 
re-infection rates upon Arf1 knockdown and a stark decrease after MAP1LC3A and 
MAP1LC3B knockdown were chosen for further analysis. 
 
 
Figure 14: Overview of the plate layout and distribution of siRNA controls and targets. Cells were seeded in the 
outer wells, but were left unused to avoid edge effects. 
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3.2.1 Quality control of the primary screening data 
As a first step in the data analysis quality control of the data was performed. For this a plate 
to plate correlation coefficient matrix was generated for each parameter of the assay. Figure 
15 Error! Reference source not found.shows the correlation matrix of the infectivity readout 
from apoptosis library as an example of the analysis. The matrix was generated by plotting 
the correlation coefficients of all plate pairs. As can be seen from the plot only the repeats 
plates containing same set of siRNA were highly correlated, whereas plates containing 
different siRNA sets are much less correlated (Figure 15Error! Reference source not found.). 
Through this analysis we could ensure that the data generated to be specific due to the gene 
perturbations introduced by siRNA. The correlation shown among only the repeats also 
indicates reproducibility of the assay irrespective of when the experiment was performed. 
For further analysis, only 3 repeat plates with highest correlation were chosen.  
 
3.2.2 Normalization of the primary screening data using POC and B-Score  
To rule out the concerns related to positional effects of wells within plates and to minimize 
false-positive and false-negative rates, two distinct statistical normalization methods were 
performed with the obtained infection and infectivity data. They are percent of control 
analysis (POC) (done in collaboration with Dr. Johannes Schuchhardt, Microdiscovery) and B-
Score analysis (Brideau, et al., 2003) (done in collaboration with Dr. Klaus-Peter Pleissner). 
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Figure 15: Correlation plot for plate wise quality control. The correlation coefficient matrix was calculated plate 
wise, based on all controls and samples. Red colors indicate correlation, green color anticorrelation between 
plates. Plate repeats containing the same set of siRNA showed good correlation values, whereas for plates 
containing different siRNA sets no correlation was observed. The infectivity correlation matrix for one sub-
library is displayed as an example for the whole screen. 
 
Percent of control’ is one processing method that attempts to correct for plate to plate 
variability by normalizing compound measurements relative to controls. In this method, the 
raw measurements for each compound is divided by the average of within the plate controls 
(Malo, et al., 2006). Therefore, in the percent of control (POC) analysis method, the data 
selected from the correlation analysis was subjected to two step normalization. For example, 
the normalization steps for the inclusion counts of one library are shown in Figure 16. In the 
first step of the normalization, data from individual plates were normalized to mean of the 
Luciferase control (Figure 16 a) using the following formula  
 
POC= Xi/C 
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Where, Xi is the raw measurement on the ith compound and C is the mean of the 
measurements of the control. In the second step, the normalized values were scaled and 
centered for the repeat groups based on the median of all normalized values of the plate 
(Figure 16 b).  
The B score is a robust analysis method, which uses an index of dispersion that is more 
resistant to the presence of outliers and more robust to differences in the measurement 
error distributions of the compounds (Malo, et al., 2006) in the following way.  
First, the residual (rijp) of the measurement for row i and column j on the pth plate is 
obtained by fitting a two-way median polish as defined below 
 
rijp = yijp – ŷijp = yijp – (μ+ Řip + Ĉjp) 
 
The residual is defined as the difference between the observed result (yijp) and the fitted 
value (ŷijp, defined as the estimated average of the plate (μp) + estimated systematic 
measurement offset for row i on plate p (Řip) + estimated systematic measurement column 
offset for column j on plate p (Ĉjp)). For each plate p, the adjusted median absolute 
deviation (MADp) is obtained from the rijp’s (MADp). The B score is then calculated as 
follows: 
 
Bscore= rijp / MADp 
 
A two-way median polish is first computed to account for row and column effects of the 
plate. The resulting residuals within each plate are then divided by their median absolute 
deviation to standardize for plate-to-plate variability. The B score has three advantages: it is 
nonparametric (that is, makes minimal distributional assumptions), it minimizes 
measurement bias due to positional effects and is resistant to statistical outliers. The 
resulting data from both the analysis methods was used for further analysis and hit 
classification.  
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Figure 16: POC two step normalization. Shown are the two normalization steps used in the percent of control 
(POC) analysis of the primary screen. (a) Plates were normalized using the mean of the Luciferase controls on 
each plate and (b) the normalized values were scaled and centered for the plate repeats containing the same 
set of siRNAs based on the median of all normalized values of the plate. Plate repeats are depicted in the same 
color. Plates from one sub-library are displayed as an example for the whole screen. 
 
3.2.3 Statistical analysis and hit classification of the primary screen 
Two different statistical methods were used for the analysis of the primary screen data with 
two different normalization methods described in 3.2.2. One of the methods was the cellHTS 
software package implemented in Bioconductor/R developed specifically to analyze cell-
based high-throughput RNAi screening data. Data was normalized using the B-Score 
normalization available within the package. As a next step in the analysis, hits were scored 
by transforming the normalized measurements into z-scores for their statistical significance. 
This step calculates a single number, the Z score, for each sample. Hits were then classified 
by defining thresholds of the z-score for both up and down regulating phenotypes, which 
were 3 and -1 respectively. A total of 204 targets were identified as primary hits with this 
method (Figure 17 B-score). 
43 
 
 
Figure 17: Statistical analysis for the primary screen. Infectivity data of cells transfected with a pool of two 
siRNAs targeting one specific gene were analyzed in parallel using two statistical normalization methods; B-
Score and percent of control (POC). Negative controls are marked in green, positive controls in red and samples 
in black. Lines indicate the defined thresholds used for primary hit definition. All 80 overlapping primary hits 
from both statistical analysis methods and 26 non-overlapping primary hits exclusively from each B-Score and 
POC methods were chosen for hit validation 
 
The second statistical method was custom designed in which percent of control 
normalization was used. To measure the statistical significance of the data p-values were 
calculated for each of the sample. Also the log2 ratios of infectivity were calculated. Volcano 
plot was generated by plotting the log2 ratios and calculated p-values on X and Y axis 
respectively. Hits were then classified by defining p-value and fold change thresholds. A total 
of 203 targets were identified as primary hits with this method (Figure 17 POC). Comparison 
of the hits scored from each of the methods revealed 80 targets to be overlapping in both 
methods. For hit validation all 80 overlapping primary hits from both statistical analysis 
methods and 26 non-overlapping primary hits exclusively from each B-Score and POC 
methods were chosen (Figure 17). 
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3.2.4 Correlation analysis of the primary screening data 
Next I analyzed the effect of primary infection on the cell numbers. The counted nuclei of 
the transfected but uninfected (TO) plate were plotted against the counted nuclei of the 
primary infection (TI) plate for all samples The analysis showed a high correlation between 
the two sample groups, implying that the infection with Chlamydia does not have profound 
effect on the cell numbers (Figure 18 Error! Reference source not found.a).  
Next we analyzed, whether the primary screen hits are biased by changes in cell number due 
to the knockdown of the target genes. The counted nuclei number of the TO plate and the 
log2 fold change of infectivity were plotted against each other. Further the primary hits were 
marked in another color to observe distribution of the hits in relation to the variation in the 
cell number caused by knockdown of the target genes (Figure 18 b). Both the up and down 
regulating primary hits distributed throughout the plot without any specific correlation to 
the cell numbers. This clearly shows that changes of the cell number caused by siRNA 
transfections has no influence on the infectivity outcome and the primary hits identified are 
a result of specific target gene knockdown. 
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Figure 18: Correlation analysis. Cell distribution and distribution of hits (a) Shown is the correlation plot of the 
raw values of the nuclei counts for the transfected plates without infection (TO) on X axis versus the nucleus 
counts of the transfected and infected plates (TI) on the Y axis. (b) Correlation plot of the nuclei counts for the 
transfected plates without infection (TO) on X axis versus the log2-fold change of the infectivity measurements. 
The primary hits are highlighted in Red. 
 
3.2.5 Statistical analysis and hit classification from the hit validation 
The data from the hit validation was analysed with the POC method described in 3.2.2 and 
the final hits defined in to three categories in the following way: Strong hits: 2 fold change in 
the observed phenotype in the same direction as observed in the primary screen with at 
least 3 of the 4 siRNAs tested. Medium hits: 1.5 fold change in the observed phenotype in 
the same direction as observed in the primary screen with at least 3 of the 4 siRNAs tested. 
Weak hits: 1.5 fold change in the observed phenotype in the same direction as observed in 
the primary screen with at least 2 of the 4 siRNAs tested (Figure 19 Error! Reference source 
not found.a). 
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Figure 19: Statistical analysis for the hit validation data and comparison of analysis methods. (a) Hit validation 
was performed for 134 primary hits using 4 independent siRNAs targeting one specific gene. Data was analyzed 
using POC normalization in a similar way as the primary screen. Final hits were clustered into strong, medium 
and weak hits according to the biological effect and the number of positive siRNAs. (b) Number of final hits 
scored from each analysis methods used in the primary screen, as well as the overlapping genes is shown. 
 
Among the final hits 9 were the number of validated strong, medium and weak hits obtained 
with the B-score method accounting to 35% validation rate, 12 were the number of validated 
strong, medium and weak hits obtained with the POC method accounting to 46% validation 
rate and 38 were the number of strong, medium and weak hits obtained overlapping hits of 
the primary screen accounting to 48% validation rate (Figure 19 b). From this it is clear that 
the POC method for has slightly higher rate of validation rate compared to B-score method. 
A list of the all the validated hits is shown in the Table 1 
 
Note: The hits list table also depicts from which analysis method the target was chosen from 
in the primary screen in the last column, C=Overlaps, P=POC method and B=B-Score method.  
Table 1: Final Hit List 
Hit Category Gene ID Name Phenotype 
Hit fromAnalysis 
method 
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Strong 5728 PTEN Down C 
  1315 COPB1 Down B 
  1028 CDKN1C Down P 
  2261 FGFR3 Down C 
  1432 MAPK14 Up B 
  56616 DIABLO Up C 
  2987 GUK1 Up C 
  2869 GRK5 Up C 
  5894 RAF1 Up P 
  23043 TNIK Up P 
  5747 PTK2 Up C 
  3845 KRAS Up P 
  8887 TAX1BP1 Up B 
  387 RHOA Up C 
Medium 4293 MAP3K9 Down P 
  5608 MAP2K6 Down C 
  9516 LITAF Down B 
  65266 WNK4 Up C 
  701 BUB1B Up C 
  1607 DGKB Up C 
  26574 AATF Up C 
  6300 MAPK12 Up C 
  9020 MAP3K14 Up C 
  51347 TAOK3 Up P 
  23591 APR Up C 
  9891 NUAK1 Up C 
  5245 PHB Up C 
  7525 YES1 Up C 
  5570 PKIB Up P 
Weak 330 BIRC3 Down C 
  378 ARF4 Down P 
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  1152 CKB Up P 
  1196 CLK2 Down B 
  1198 CLK3 Down B 
  1716 DGUOK Up C 
  2932 GSK3B Down C 
  3678 ITGA5 Up C 
  4055 LTBR Up C 
  4843 NOS2A Up C 
  5255 PHKA1 Up C 
  5742 PTGS1 Down C 
  5930 RBBP6 Up C 
  7083 TK1 Up C 
  7422 VEGFA Down P 
  8396 PIP5K2B Up C 
  8761 PABPC4 Down C 
  8772 FADD Down C 
  8784 TNFRSF18 Up B 
  8833 GMPS Down C 
  9371 KIF3B Up C 
  10293 TRAIP Up C 
  10645 CAMKK2 Down B 
  22900 CARD8 Down B 
  65975 STK33 Up C 
  79109 MAPKAP1 Up C 
  79646 PANK3 Up C 
  80271 ITPKC Down C 
  83549 UCK1 Up C 
  118788 PIK3AP1 Up P 
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3.2.6 Ingenuity pathway analysis of the hits 
Further, the validated hits were subjected to a pathway analysis to identify signaling 
pathways which are potentially influencing Ctr infection and infectivity. For this purpose, I 
used Ingenuity Pathway Analysis software (IPA), a web based interface, which builds 
interactions based on literature evidences (done in collaboration with Dr. André P. Mäurer). 
The strong, medium and weak validated hits were independently subjected to a functional 
analysis using IPA. This program grouped the validated hits according to proposed molecular 
and cellular functions. Functional groups significant for the Fisher`s exact p-value in all three 
hit categories, were identified to be involved in cell death, cell morphology, cell cycle, cell 
signaling, cell to cell signaling, cellular assembly, small molecule biochemistry, cellular 
movement, post translational modification and amino acid metabolism. All other possible 
functions that did not meet the significance criteria were not considered for further analysis. 
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Figure 20: Pathway analysis. The validated hits were analyzed using Ingenuity Pathway Analysis (IPA) software. 
These hits were revealed to be involved in several molecular functions. From the identified functions, hits were 
subjected to network analysis. Shown is the simplified network based on the interactions predicted by IPA. Hits 
are designated in colors based on infectivity phenotypes: green for down regulation and red for up regulation. 
Other proteins (non-hits) were added to complement the networks which are displayed in white. The 
connections between the proteins are depicted with letters: A= Activation, PP=protein protein interaction, E= 
Expression, RB= Phosphorylation, MB=Member, I=inhibition. The solid lines show direct and the dashed lines 
show indirect interactions. 
 
Further, the hits from these groups were used to develop network using IPA, based on 
protein-protein interaction, activation, inhibition and transcription. Several possible signaling 
pathways were identified from this analysis. Interestingly, Ras and Raf-1 were found to have 
a central role in the downstream signaling in all the identified networks. Further, the 
complex networks were curated to simplify into one single network for better clarity (Figure 
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20). Specifically, Ras and Raf-1 depletion was found to increase Ctr infectivity in the screen. 
This was seemingly in contradiction to previous evidences (Su, et al., 2004). Therefore, it is 
interesting to elucidate the role of Ras and Raf-1 in Chlamydia infections. 
 
3.3 Functional characterization  
3.3.1 Time course analysis of the Chlamydia infected cells  
A previous publication has described the activation of the Ras-Raf-Mek-Erk pathway after Ctr 
infection leading to the activation of cPLA2 by phosphorylation (Su, et al., 2004). This study 
primarily employed chemical inhibitor to inhibit Mek and Raf1 and showed that Mek 
inhibition leads to decrease Ctr infectivity as well as of cPLA2 phosphorylation. However, our 
screening results strongly suggested that Ras and Raf knockdown led to increased Ctr 
infectivity. Therefore we decided to compare the screening results and literature by blocking 
the Ras-Raf-Mek-Erk pathway with chemical inhibitors as well as siRNA.  
 
 
Figure 21: Time course analysis of Ctr infected HeLa cells. HeLa cells infected with MOI 3 of Ctr, were harvested 
at the indicated time points after infection and subjected to immunoblot analysis for Ras, Raf, Erk, cPLA2, 
phospho-ERK (pERK1/2) and phospho-cPLA2 (p-cPLA2). β-actin was used as loading control. A representative 
blot of three independent experiments is shown 
 
To determine the optimal time point of infection to study the regulation of the 
Ras/Raf/Mek/Erk pathway and cPLA2 activation upon Chlamydia infection, a time course 
analysis was performed. 
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HeLa cells seeded in 6 well plate one day before infection were infected with MOI 3 of C. 
trachomatis. Samples were harvested by adding SDS sample buffer directly to the wells after 
0, 8, 20, 30, 40 hpi. As a positive control for the activation of Erk pathway cells were treated 
with 100 ng/ml of EGF for 5 minutes before harvesting the cells similar to infected cells. 
Samples were then boiled for 5 minutes before subjecting to western blot analysis of Ras, 
Raf1, Erk, p-Erk, cPLA2 and p-cPLA2 using specific antibodies. As expected, HeLa cells show 
strong phosphorylation of Erk1/2 and cPLA2 starting from 8h until 44h post infection. 
However the levels of Ras, Raf1, Erk and cPLA2 remained unchanged throughout the 
infection time course (Figure 21Error! Reference source not found.). As the previous studies 
employed the 30h post infection time point and also because strong up-regulation of the p-
Erk1/2 and p-cPLA2 was observed in our study at the same time point, we decided to use 
this time point of infection for further evaluation.  
 
3.3.2 Mek Inhibitor U0126 leads to decrease in Erk and cPLA2 
phosphorylation and Chlamydia infectivity 
To study the effect of Mek inhibition upon treatment with the chemical inhibitor U0126, 
HeLa cells seeded in a 6 well plate one day before infection and were infected with MOI 3 of 
C. trachomatis. 2 hpi medium was replaced with fresh IM containing either 10 or 100µM 
U0126 inhibitor or left without treatment and the inhibitor was maintained throughout the 
infection duration. 30 hpi samples were harvested and subjected to western blot analysis of 
Ras, Raf1, Erk, p-Erk, cPLA2 and p-cPLA2. Duplicates of the samples treated identically were 
used for determination of infectivity as described in 5.2.5.2. 
HeLa cells showed strong phosphorylation of Erk1/2 and cPLA2 at 30h post Ctr infection, 
whereas infection in the presence of the MEK inhibitor U0126 led to reduced 
phosphorylation of Erk as well as of cPLA2 (Figure 22 a). Consistently, treatment with U0126 
also led to decreased infectivity compared to mock treated and infected cells (Figure 22 
Error! Reference source not found.b). This is very much in agreement with the earlier 
publication (Su, et al., 2004), implying that Mek inhibition using U0126 leads to decrease in 
the Erk phosphorylation and subsequent cPLA2 activation. 
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Figure 22: Inhibition of Mek by Chemical inhibitor U0126 leads to decrease in Erk and cPLA2 phosphorylation 
and Chlamydia infectivity. (a) Non infected and Ctr infected HeLa cells with and without UO126 inhibitor 
treatment, were harvested 30h pi and subjected to immunoblot analysis for Ras, Raf, Erk, cPLA2, phospho-ERK 
(pERK1/2) and phospho-cPLA2 (p-cPLA2). -actin was used as loading control. A representative blot of three 
independent experiments is shown. (b) Non infected and Ctr infected HeLa cells with and without the inhibitor 
UO126 were lysed 48h post infection and used to reinfect freshly seeded cells. These cells were fixed 24h post 
reinfection and the infectivity quantified using automated microscopy. Shown are the ±SD of three 
independent experiments normalized to mock treated infected cells. 
 
3.3.3 Knockdown of Mek1/2 by siRNA also leads to decrease in Erk1/2 
phosphorylation 
Next I analyzed whether the knockdown of Mek1/2 also has same effect on Erk activation as 
observed with the chemical inhibitor U0126. HeLa cells seeded in 12 well plate one day 
before were transfected either with siRNA targeting Mek 1 and Mek2 together (siMek1/2) or 
siRNA targeting Luciferase (siLuci) was used a transfection control. One day later the cells 
were detached and reseeded into 6 well plates and incubated further 48 hours. Three days 
post transfection the cells were infected with MOI3 of C. trachomatis. Samples were 
harvested 30 hpi subjected to western blot analysis of, p-Erk, and Mek. 
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Figure 23: Knockdown of Mek1/2 leads to decrease in Erk phosphorylation. Non infected and Ctr infected. HeLa 
cells with siRNA targeting Luciferase (siLuci) and MEK1/2 (siMEK1/2) were harvested 30 hpi and subjected to 
Western blot analysis for MEK1/2 and pERK. β-actin was used as loading control. A representative blot of three 
independent experiments is shown. 
 
These results show an increase of Erk phosphorylation after Ctr infection which decreased 
almost to the basal level in Mek1/2 KD cells (Figure 23). In the primary screen we also 
observed a clear decrease in the infectivity after Mek knockdown (data not shown). This 
suggests that the KD of Mek using siRNA has the same effect as the chemical inhibitor U0126 
in downstream activation of Erk, implying the requirement of Mek for activation of Erk and 
its downstream effectors in Chlamydia infection 
 
3.3.4 Activation of Erk after Chlamydia infection does not depend on Ras and 
Raf1, and knockdown of Ras and Raf1 leads to increased infectivity  
Knockdown of Ras or Raf1 consistently led to increase in Chlamydia infectivity in the screen 
and were subsequently identified as strong hits from the hit validation. However, it was 
published that the inactivation of Raf1 by chemical inhibitor GW5074 reduces the activation 
of Erk and cPLA2 (Su, et al., 2004). To clarify the discrepancies from the published data and 
our results, we decided to further examine the involvement of Ras and Raf1 by siRNA based 
gene knockdown. 
After knockdown of Ras and Raf1 (described in 5.2.9), subsequently HeLa cells were infected 
with MOI 3 of C. trachomatis (described in 5.2.4). Samples were harvested 30 hpi and were 
subjected to western blot analysis of, Ras, Raf1, Erk, p-Erk, cPLA2 and p-cPLA2 (described in 
5.2.13) 
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In contrast to the observation of Mek1/2 inhibition by chemical inhibitor and siRNA, Ras or 
Raf1 knockdown did not decrease the Erk and cPLA2 phosphorylation (Figure 24 Error! 
Reference source not found.a). This clearly suggests that Ras and Raf1 are not involved in 
activation of Erk in Chlamydia infection. It was also observed that knockdown of Ras or Raf1 
led to increase in the Chlamydia infectivity compared to Luciferase transfected samples 
(Figure 24 b) contrary to that observed with Mek inhibition implying that knockdown of 
either Ras or Raf1 offers growth advantage to Chlamydia within the host cells. 
 
 
Figure 24: Effects of Ras and Raf1 knockdown on ERK and cPLA2 phosphorylation and Chlamydia infectivity. (a) 
Non infected and Ctr infected HeLa cells with siRNA targeting Luciferase, Ras and Raf1 were harvested 30h pi 
and subjected to Western blot analysis for Ras, Raf1, Erk, cPLA2, p-ERK1/2 and p-cPLA2. For Ras and Raf1 
knockdown two independent siRNAs were used indicated as 1 and 2. -actin was used as loading control. A 
representative blot of three independent experiments is shown. (b) Non infected and Ctr infected HeLa cells 
with and without siRNA targeting Luciferase, Ras and Raf1 were lysed 48h post infection and used to reinfect 
freshly seeded cell. For Ras and Raf1 kockdown two independent siRNAs were used indicated as 1 and 2. These 
cells were fixed 24h post reinfection and the infectivity quantified using automated microscopy. Shown are the 
±SD of three independent experiments normalized to infected and siLuci transfected cells. 
 
3.3.5 Raf1 is inactivated by Ser259 phosphorylation after Chlamydia infection 
in an AKT1/2 dependent manner 
My results thus far show that Erk phosphorylation is Raf1 independent after C. trachomatis 
infection. Phosphorylation of Ser259 has been reported to inactivate Raf1 (Rommel, et al., 
1996; Zimmermann and Moelling, 1999), therefore I investigated if Raf1 phosphorylation is 
influenced in Chlamydia infection. 
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HeLa cells were transfected with siRNA targeting Luciferase (siLuci) and Akt 1 and 2 together 
(siAkt 1+2), 3 days post transfection cells were infected with MOI 3 of C. trachomatis. 
Samples were harvested 30 hpi and were subjected to western blot analysis of Akt, phospho-
Erk and phospho-Raf1 (Ser259) (described in 5.2.13). Chlamydia infected cells showed an 
increased phosphorylation of Raf1 at Ser259, confirming the hypothesis. However, 
knockdown of Akt led to decreased Raf1 phosphorylation to the basal uninfected levels, 
implying that Akt1/2 is required for phosphorylating Raf1 at Ser259 (Figure 25). On the other 
hand, increased phosphorylation of Erk upon Chlamydia infection was not affected by 
knockdown of Akt (Figure 25). Taken together this data strongly suggests that Chlamydia can 
inactivate Raf1 by Akt dependent phosphorylation at Ser259. 
 
 
Figure 25: Inactivation of Raf1 at Serine 259 after Ctr infection depends on AKT. Non infected and Ctr infected 
HeLa cells with siRNA targeting Luciferase (siLuci) and Akt (siAkt1+2) were harvested 30 hpi and subjected to 
Western blot analysis for Akt, phospho-Erk and phospho-Raf1 (Ser259). -actin was used as loading control. A 
representative blot of three independent experiments is shown. 
 
3.3.6 Raf1 and phospho Raf1 are redistributed to the Chlamydia inclusion 
and co-localize with 14-3-3β 
Upon Akt dependent Ser259 phosphorylation, Raf1 is able to bind to 14-3-3β (Muslin, et al., 
1996; Zimmermann and Moelling, 1999). In addition during infection 14-3-3β has been 
shown to be recruited to the Chlamydia inclusion (Scidmore and Hackstadt, 2001). Therefore 
I investigated how the cellular localization of Raf1 is affected by Chlamydia infection. 
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Figure 26: Raf1 and phospho Raf1 are redistributed to the Chlamydia inclusion. Non infected and Ctr infected 
HeLa cells fixed 30h pi, stained for 14-3-3 beta and either (a) Raf1 or (b) phospho-Raf1. Images were acquired 
with a confocal microscope. Overlay and phase contrast images are shown to demonstrate the co-localization 
and Chlamydia inclusion respectively. Representative images of three independent experiments are shown. 
 
To determine the cellular localization of Raf1 and p-Raf1 (Ser259) in infected cells confocal 
microscopy was used. HeLa cells infected with an MOI 2 of C. trachomatis were fixed 30 hpi. 
The samples were then stained with antibodies targeting Raf1and 14-3-3β or p-Raf1 (Ser259) 
and 14-3-3β. 
In uninfected cells both Raf1 and p-Raf1 (Ser259) were observed dispersed throughout the 
cytoplasm with no specific pattern of accumulation. The same pattern of distribution was 
also observed for 14-3-3β (Figure 26 a and b top panel). However, in Chlamydia infected cells 
Raf1 and p-Raf1 (Ser259) were observed in close proximity to the chlamydial inclusion 
(Figure 26 a and b bottom panel). The pattern of distribution of Raf1 and p-Raf1 (Ser259) 
was found to be similar to that of 14-3-3β. Furthermore, the overlay of Raf1 and p-Raf1 with 
14-3-3β from respective samples demonstrated a high degree of co-localization of both the 
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proteins at the inclusion membrane. This clearly indicates that upon infection with C. 
trachomatis the Raf1 is re-localized to the inclusion membrane in a 14-3-3β dependent 
manner. 
 
3.3.7 Redistribution of Raf1 to the sub cellular membrane fraction after 
Chlamydia infection depends on Akt and 14-3-3β 
To further confirm Raf1 re-localization to the inclusion membrane and the involvement of 
14-3-3β and Akt in this process. I performed a sub cellular fractionation experiment of 
uninfected and Ctr infected cells with knockdown of either Luciferase, 14-3-3β or Akt as 
described in 5.1.7.1. 
In uninfected cells with Raf1 was found being equally distributed between the cytosolic and 
the membrane fractions, whereas after infection it was predominantly found in the 
membrane fraction implying that Raf1 is redistributed to Chlamydia membrane fraction 
(Figure 27 Error! Reference source not found.a). Uninfected cells with Akt knockdown 
showed a similar distribution pattern as cells with Luciferase knockdown for Raf1 (Figure 27 
b).  
In contrast, after Akt knockdown Raf1 was detected equally in the membrane and cytosolic 
fraction in Chlamydia infected cells. This clearly suggests that Raf1 redistribution to the 
membrane fraction is dependent on Akt mediated phosphorylation of Raf1 at Ser259 (Figure 
27 b). 
In comparison to luciferase knockdown, uninfected cells with 14-3-3β knockdown showed a 
prevalent distribution of Raf1 in the cytosolic fraction (Figure 27 c). Also in infected cells, 14-
3-3β knockdown did not lead to a redistribution of Raf1 to the membrane fraction (Figure 27 
c), proving the impact of 14-3-3β on Raf1 redistribution. 
Altogether, the data strongly suggests that Raf1 is recruited to the Chlamydia inclusion in an 
Akt and 14-3-3β dependent manner. 
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Figure 27: Redistribution of Raf1 to membrane fraction depends on Akt and 14-3-3β. Non infected and Ctr 
infected HeLa cells treated with siRNA targeting (a) Luciferase (b) Akt1/2 or (c) 14-3-3β were separated into sub 
cellular fractions using Sub cellular Proteome Extraction Kit (Calbiochem) 30h post infection and subjected to 
Western blot analysis for Raf1 and chlamydial Hsp60. Calpain, Lamp1, Lamin a/c and Cytokeratin8 were used as 
markers for cytosolic, membrane/organelle, nuclear and cytoskeletol sub cellular fractionations. The sub 
cellular fractionation markers were found to be similarly distributed in all the conditions; therefore only from 
the 14-3-3β samples are shown as an example. 
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4 Discussion 
Pathogenic bacteria have evolved various strategies to create a niche for replication inside 
the host. For instance, as an obligate intracellular pathogen, Chlamydiae rely on host cells for 
all aspects of their survival, from the initial attachment with the host cell membranes, to 
cellular invasion, acquisition of host cell metabolites and intracellular replication (Coombes, 
et al., 2002). Despite that with the available experimental approaches thus far several 
molecular mechanisms of the chlamydial pathogenesis have been elucidated, however the 
overall processes underlying the infection are only partially understood.  
The ease and availability of RNAi technique to inactivate gene expression in the eukaryotic 
cells provides the opportunity to uncover the novel host-pathogen interactions which might 
otherwise be overlooked.  
Therefore my study involves RNAi screening with Chlamydia in human cells, which is the first 
functional RNAi screen to date with a possibility to identify host cell factors important for 
Chlamydia throughout its complete developmental cycle including entry in to host cells, 
survival, replication and re-differentiation in to RBs. Establishment of such a screen has to 
deal with several parameters ranging from standardizing cell culture seeding procedures to 
handling of large amounts of highly infectious bacteria for successful establishment of 
synchronous infection in 96 well formats (Echeverri, et al., 2006). Therefore I have carefully 
optimized the infection procedure which would allow me to monitor both increase and 
decrease in primary infection and infective progeny as a consequence of target gene 
knockdown through siRNA (Figure 8Error! Reference source not found.). Cell lysis conditions 
using detergent concentration, where it efficiently lyses cells releasing all the infectious 
Chlamydia particles without any influence on the target cells of the infectivity plate (Figure 
9), were also optimized. Identification of activating and inhibitory controls enabling me to 
monitor the functionality of the assay throughout the screen (Figure 10) was crucial for the 
successful screening. Optimum Chlamydia multiplicity of infection with a range, so that 
changes in the infection and infectivity resulting from knockdown of target genes could be 
monitored (Figure 11) was established. I also established optimal cell numbers allowing me 
to score phenotypes for most of the siRNAs tested. With these conditions, I established a 
robust and specific assay, described in detail in section 3.1.1. This semi-automated, highly 
sensitive and robust assay combined with sophisticated statistical algorithms for analysis 
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enabled me to perform an unbiased screen to identify host cell factors involved in the entry 
and survival of Chlamydia in host cells. 
In the past few years several RNA interference screens have been performed in 
Caenorhabditis elegans, Drosophila and human cells. These screens have shed light on 
various cellular processes such as cell viability (Boutros, et al., 2004), cytokinesis (Eggert, et 
al., 2004), Wnt Signaling (DasGupta, et al., 2005), JAK/STAT Signaling (Baeg, et al., 2005), and 
mechanisms of host–pathogen interaction, including Listeria and Mycobacterium 
pathogenesis (Agaisse, et al., 2005; Cheng, et al., 2005; Philips, et al., 2005), Candida albicans 
phagocytosis (Stroschein-Stevenson, et al., 2006), and L. pneumophila exploitation of the 
early secretory pathway (Dorer, et al., 2006) as well as to identify host proteins that are 
required for viral entry and replication (Brass, et al., 2008; Supekova, et al., 2008). 
Specifically there have been two studies focusing on Chlamydia using RNAi screens in 
Drosophila SL2 cells. One of the screens identified the Abl kinase and PDGFR Signaling to be 
involved in C. trachomatis entry of host cells (Elwell, et al., 2008) and the other revealing the 
involvement of the Tom complex in Chlamydia infections (Derre, et al., 2007). Although 
these studies have uncovered new Chlamydia host cell interactions, they are limited in their 
ability to monitor the processes involved throughout the developmental cycle of Chlamydia 
infection in the host cells. Though there are some experimental evidence concerning use of 
Drosophila SL2 cells as a model for Chlamydia infections, however it does not completely 
mimic the human host conditions as Chlamydia cannot complete their developmental cycle 
in these cells (Elwell and Engel, 2005). In contrast to the Chlamydia screens in Drosophila SL2 
cells an RNAi screen in HeLa cells, in which Chlamydia can undergo a complete life cycle 
provides much deeper insights into the interplay between the host and pathogen. 
When it was initially discovered, RNA interference was considered as a revolutionary tool, 
both because of its ease and of its specificity. But relatively shortly after the application of 
RNAi human cells, a concern was raised about off-target effects. Therefore, in order to 
ensure the phenotypes observed in the primary screen, 132 hits were validated with 
additional siRNAs. Similar phenotypes obtained with several siRNAs targeting the same 
genes therefore more likely to rely on the loss of target gene function than on off-target 
effects.  
It was suggested that only genes that show a perfect complementation to a siRNA would be 
targeted, and mismatches of just one nucleotide would be sufficient to disrupt this effect 
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(Elbashir, et al., 2001). However, more recently, several reports suggested that this rule is 
not always applying and that expression of several unintended genes is also affected by the 
use of a given siRNA (Birmingham, et al., 2006; Jackson, et al., 2003; Lin, et al., 2005; Ma, et 
al., 2006). One possibility could be that siRNA molecules can be processed in the cells like 
the endogenous miRNAs. The human genome, as well as the genomes of other organisms 
encodes genes generating RNA stem loop structures (Bartel, 2004; Kim and Nam, 2006). 
These molecules are then successively processed by Drosha and Dicer, two RNaseIII-like 
enzymes generating an imperfect siRNA-like duplex (Lee, et al., 2003). Conversely to siRNAs 
that induce cleavage of their mRNA targets (Elbashir, et al., 2001; Hammond, et al., 2000), 
miRNAs are mainly responsible for translational repression (Bartel, 2004; Kim and Nam, 
2006). Partial complementarity is sufficient, which results in down-regulation of multiple 
genes by a single miRNA. The off-target effects observed upon siRNA treatment could 
therefore arise from partial complementarity to untargeted genes and subsequent inhibition 
of translation (Doench, et al., 2003; Saxena, et al., 2003; Scacheri, et al., 2004; Zeng, et al., 
2003). However, since some miRNAs have also been shown to regulate their targets at the 
mRNA level (Lim, et al., 2005), similar unintended mRNA down regulation could also occur 
upon siRNA treatment (Jackson, et al., 2003; Lin, et al., 2005). 
Among the screens that have been previously carried out, although some of them did not 
seem to suffer from off-target effects (Kittler, et al., 2004; MacKeigan, et al., 2005; 
Pelkmans, et al., 2005), whereas others concluded that their major phenotypes were actually 
due to the down-regulation of unintended genes (Lin, et al., 2005; Ma, et al., 2006). In 
particular, Lin et al. showed that a partial complementation of only 7 nucleotides was 
sufficient to induce mRNA down-regulation of an unintended gene (Lin, et al., 2005). These 7 
nucleotides correspond to the seed region of miRNA, which is also necessary for miRNA-
induced down-regulation (Birmingham, et al., 2006; Jackson, et al., 2006; Lin, et al., 2005). 
The difference in off-target occurrence between these various screens could arise from 
several causes. First, in the screens that do not show off-targets, only a small subset of genes 
has been tested. It is therefore not unlikely that other phenotypes are due to off-target 
effects. Furthermore, it is possible that some cellular processes would be more sensitive to 
off-target effects than others. In the case of lipid metabolism, several miRNAs have been 
implicated in its regulation (Esau, et al., 2006; Esau, et al., 2004; Krutzfeldt, et al., 2005; 
Krutzfeldt and Stoffel, 2006). It is possible that several genes implicated in lipid homeostasis 
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are targets of miRNAs and would therefore be more sensitive to unintended down 
regulation by siRNA (Jackson, et al., 2006; Stark, et al., 2005). Supporting this hypothesis, a 
high proportion of genes implicated in lipid metabolism have long 3’ untranslated region 
(UTR), the part of the gene that is preferentially targeted by miRNAs. Nevertheless, some 
miRNAs still wait to be discovered and other sequences in the 3’UTR could be responsible for 
the off-targeting. Unfortunately, considering the high number of genes that contain a 7 nt 
complementarity to a given siRNA in their 3’UTR, such homology cannot be used to identify 
the potential off-targets (Birmingham, et al., 2006). 
Several suggestions have been made to decrease the occurrence of off-target effects. One of 
them is the use of lower siRNA concentration. It has been suggested that decreasing the 
siRNA concentration would not impair down-regulation of the targeted gene, but decrease 
the occurrence of off-target effects (Persengiev, et al., 2004). Even though this might be true 
for very efficient siRNAs, however the down-regulation of the target may be affected upon 
use of a less potent siRNA, thereby increasing the occurrence of false negatives in a screen. 
For this reason, high siRNA concentrations were also used in previous screens (MacKeigan, 
et al., 2005; Pelkmans, et al., 2005). Furthermore, decreasing the siRNA concentration most 
of the time did not disrupt the potential off-target phenotypes (Jackson, et al., 2003). 
Similarly, esiRNAs have been suggested to generate less off-target effects due to the low 
concentration of any individual sequence (Kittler, et al., 2007). However, although some 
esiRNAs were very potent in knocking down their targets, some others showed only minor 
down-regulation, thereby also increasing the occurrence of false negatives in a screen.  
Pooling of multiple siRNAs targeted against the same gene has been proposed to increase 
(http://www.ambion.com/techlib/tn/121/11.html) or decrease 
(http://www.dharmacon.com/docs/article_pooling.pdf) off-target effects. Therefore 
another suggestion is to directly compare the effect of several individual sequences 
targeting the same gene independently in the primary screen. Although variation in 
efficiency may result in different phenotypes, it again appears as a sensible way to directly 
select potential real targets. In addition, nowadays, most suppliers have improved their 
siRNA design to reduce off-target effects. Also further understanding of the RNA 
interference process and improvement of the siRNA design accordingly may therefore 
support the generation meaningful screening results in the future. Till date there is no 
consensus on the best strategy with respect to pooling several siRNAs against one gene or to 
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screen them independently. Keeping in mind all the available knowledge, I decided to use a 
low siRNA concentration of 10nM in combination with a very efficient transfection reagent 
Hiperfect (Qiagen). Additionally I also decided to incorporate both the strategies of pooling 
and non-pooling of siRNA sequences in this study. The primary screen was performed with 
two siRNA sequences targeting a single gene pooled together in one well as it would be 
more expensive to screen them separately in the primary screen with a large number of 
samples. However, to rule out the false positives due to off-target effects hit validation was 
performed by using 4 independent siRNA sequences targeting the same gene for all the 132 
hits from the primary screen. By this combinatorial approach I aimed to produce a least 
amount of false positive hits. 
RNAi screening experiments using large siRNA libraries targeting genes generate a huge 
amount of data. Therefore, they require a robust statistical analysis tools in order to identify 
the most effective siRNAs and to score high confidence hits. There are currently no standard 
statistical tools for analysis of RNAi screening data unlike for gene expression data analysis. 
Therefore it is critical to adopt and develop appropriate statistical methods depending on 
the individual needs. A well-defined and highly sensitive test system requires both quality 
control and accurate measurements. Within-plate reference controls are typically used for 
these purposes. Controls help to identify plate-to-plate variability and establish assay 
background levels. Normalization of raw data removes systematic plate-to-plate variation, 
making measurements comparable across plates. For that reason, I decided to use two 
different statistical analysis methods for scoring hits from the primary screen data. The first 
method was using cellHTS a free software package specifically developed for RNAi screening 
data analysis based on R and Bioconductor (Boutros, et al., 2006). In this method data 
normalization was performed with the B Score method before scoring the hits (plate based 
normalization). The other was a custom developed method where percent of control (POC) 
normalization was used (control based normalization). A total of 327 targets were identified 
as primary hits combinedly from both statistical analysis methods. All the primary hits were 
ranked based on the strength of the phenotype identified in each analysis method and the 
overlapping hits between both analyses were determined. All the top 80 candidate genes 
identified to be overlapping from both the analysis methods were chosen for further 
validation, in addition 26 top non-overlapping candidates each from B Score and POC 
analysis methods respectively were identified and chosen for validation. This was done 
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mainly to ensure selection of high confidence hits from the primary screen and also to 
evaluate the best statistical analysis method. It was intended to be standardized for the 
future high throughput RNAi screen data analysis at the screening facility of Max Planck 
Institute for Infection Biology.  
POC analysis method was employed to score hits from the hit validation of the 134 primary 
hits. The final hits were classified in to three categories based on the fold change and the 
number of siRNAs the phenotype was scored from as described in detail in the section 3.2.5 
of results.  
Among the strong hits identified leading to significant reduction in the chlamydial infective 
progeny upon knockdown were, PTEN (phosphatase and tensin homolog) a negative 
regulator of intracellular levels of phosphatidylinositol-3,4,5-trisphosphate and AKT/PKB 
Signaling pathway, COPB1 (Coatomer protein complex, subunit beta 1) a protein subunit of 
the coatomer complex associated with non-clathrin coated vesicles, CDKN1C (Cyclin-
dependent kinase inhibitor 1C ) a strong inhibitor of several G1 cyclin/Cdk complexes and 
negative regulator of cell proliferation, FGFR3 (Fibroblast growth factor receptor 3) a 
member of the fibroblast growth factor receptor family. In the group of strong hits leading to 
increase in the chlamydial infective progeny upon knockdown were, MAPK14 (Mitogen-
activated protein kinase 14) a MAP kinase family member known to be involved in stress 
related transcription and cell cycle regulation, as well as in genotoxic stress response, 
DIABLO (Drosophila diablo homolog ) a moderator of the caspase inhibition of IAPs, GUK1 
(Guanylate kinase 1), GRK5 (G protein-coupled receptor kinase 5) a regulator of the activated 
forms of G protein-coupled receptors, RAF1 (v-raf-1 murine leukemia viral oncogene 
homolog 1) a MAP3 kinase which functions downstream of the Ras family of membrane 
associated GTPases, TNIK (TRAF2 and NCK interacting kinase) known to activate the c-Jun N-
terminal kinase (JNK) pathway and regulate actin cytoskeleton by acting as a Rap2 effector, 
PTK2 (Protein tyrosine kinase 2) a member of the FAK subfamily of protein tyrosine kinases 
involved in cell growth and intracellular signal transduction pathways, KRAS (Kirsten rat 
sarcoma viral oncogene homolog) a member of the small GTPase super family implicated in 
various malignancies, TAX1BP1 (human T-cell leukemia virus type I binding protein 1), RHOA 
(Ras homolog gene family, member A) a member of the Ras homology family of small 
GTPases involved in the regulation of cytoskeleton. The hits represent a broad range of 
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cellular functions and molecular processes emphasizing the diverse interactions between 
Chlamydia and host cell. 
Cellular responses are orchestrated by complex molecular networks. Information contained 
in primary databases and in the experimental literature relevant to these networks is 
extensive. Therefore, we used Ingenuity Pathway Analysis software (IPA), a web-based 
interface, to query molecular interactions, biological functions, for generating a customized 
pathway analysis. The validated hits were grouped according to proposed molecular and 
cellular functions. These groups were subjected to a network analysis using IPA to find 
additional involved molecules. Connections between these molecules were generated using 
protein-protein interactions, activation, inhibition and phosphorylation.  
From our results, it was found that depletion of the lymphotoxin beta receptor (LTBR), 
Diablo, TNFR18 and PIP3k4b led to increased Ctr infectivity. In line with this, Leukotriene B4 
(LTB4) and IL-6, interacting with LTBR and have been described to increase after C.suis 
infection (Reinhold, et al., 2008). PIP4K2B KD led to increased Ctr growthin our results, which 
is shown to bind to TNFRSF1A in MCF7 cells (Castellino, et al., 1997). TNFRSF1A has been 
shown to be reduced after Ctr infection (Paland, et al., 2008). Supporting our results, 
TNFRSF1A as well as TNFSF9 and TNFRSF18 have been described to lead to increased Cpn 
growth when inhibited with TNF-alpha (Njau, et al., 2009). Moreover, Diablo interacts with 
IAPs (Rajalingam, et al., 2007), which are essential for anti-apoptosis in Ctr infected cells 
(Rajalingam, et al., 2006). Diablo, LTBR, TNFR18 and TNFRSF1A can interact with TRAF2 
(Esparza and Arch, 2005; Kuai, et al., 2003; Papin and Subramaniam, 2004), a protein 
required for TNF-alpha-mediated activation. TRAF2 can interact with the validated hits 
TAOK3, MAP3K14, TNIK and MAP2K1, leading to activation of JNK (Darnay, et al., 1999; Fu, 
et al., 1999; Murai and Pasquale, 2003; Taira, et al., 2004). JNK has been described to 
interact with Ras (Tibbles and Woodgett, 1999) and depletion of Ras and Raf1, part of major 
signaling pathways led to increased infectivity. Also prohibitin which interacts with Raf1 
(Rajalingam and Rudel, 2005), was identified to increase infectivity upon depletion. 
Interestingly, depletion of MAP2K6, a downstream target of Raf1 led to decreased 
infectivity. Ras and Raf1 were identified to play a major role in the described networks. The 
observed increase in Ctr infectivity upon Ras and Raf1 depletion, as well as the decrease in 
infectivity upon MAP2K6, a member of the Mek group suggests a different role of Ras, Raf1 
and Mek during infection. Knockdown of Ras and Raf components of the Ras/Raf/Mek/Erk 
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pathway seem to significantly benefit the Chlamydia growth as the infectivity from this 
knockdowns was 2-3 fold more compared to control in at least 3 of the 4 siRNAs tested for 
each target. We focused here on the role of Ras and Raf1. The remaining quantitative and 
qualitative data obtained are open to future in depth analyses. 
The Ras/Raf/Mek/Erk cascade is a key signaling pathway involved in events such as cell 
proliferation, cell-cycle and apoptosis (McCubrey, et al., 2007; Steelman, et al., 2004). Also in 
Chlamydia infections, Erk activation is associated with activation of cPLA2 (Su, et al., 2004), 
induction of IL8 (Buchholz and Stephens, 2008), and stabilization of the anti-apoptotic Bcl-2 
family member Mcl-1 (Rajalingam, et al., 2008). In case of the canonical cascade Mek1/2 
activated by Raf1 phosphorylates Erk1/2 on specific tyrosine and threonine residues leading 
to its activation (McCubrey, et al., 2007). Subsequently Erk1/2 directly phosphorylates a 
variety of transcription factors including c-Jun and NF kappaB (Nakano, et al., 1998; 
Steelman, et al., 2004). Our results showed a clear increase in the chlamydial infective 
progeny upon knockdown of either Ras or Raf in contrast to the published reports by Su et 
al. (2004). To clarify these seemingly contradictory results and to further elucidate the 
underlying molecular mechanism involved in the upregulation of chlamydial infectivity in the 
Ras and Raf1 knockdowns, extensive biochemical as well as microscopical characterisation of 
these factors was undertaken. 
My initial experiments of time course infection of HeLa cells with C. trachomatis to verify if 
Erk1/2 and cPLA2 phosphorylation showed comparable results which are in concordance to 
the previously published results (Su, et al., 2004) (Figure 21). Subsequent experiments 
comparing the Erk and cPLA2 phosphorylation in the presence of chemical inhibitor U0126 
used by Su et al. also showed a decreased activation of Erk and cPLA2 and a decrease in the 
Chlamydia infectivity (Figure 22Error! Reference source not found.) what is also in 
compliance with the previous results. In addition knockdown of Mek1/2 using siRNA also 
showed decreased Ekr1/2 phosphorylation (Figure 23) and Chlamydia infectivity. Taken 
together, these results suggest that the phosphorylation of Erk1/2 and subsequent 
activation of cPLA2 are important for better growth of Chlamydia inside the host cells. Also 
showed, evidently that the activation of Erk1/2 in Chlamydia infections is dependent on 
Mek1/2.  
However, knockdown of either Ras or Raf1 using siRNA in Chlamydia infections did not led to 
a decrease in of Erk1/2 and cPLA2 phosphorylation (Figure 24Error! Reference source not 
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found.). Furthermore, I could also observe a prominent increase in the Chlamydia infectivity 
in the knockdown conditions of both Ras and Raf1 confirming the results of the screen. Thus 
it is very unlikely that the Ras and Raf1 are involved in the downstream activation of Mek1/2 
and Erk1/2 of the Ras/Raf/Mek/Erk pathway in Chlamydia infections. In case of the 
Mycobacterium tuberculosis infection of monocytes/macrophages, Erk1/2 activation has 
also been shown to be independent of Ras and Raf1 (Yang, et al., 2007)). However our 
results from Ras and Raf1 are seemingly in contradiction with the previously published 
results (Su, et al., 2004). Therefore, I further investigated this apparent discrepancy in my 
results and the existing knowledge about the activation of this important Signaling pathway 
in Chlamydia infections. One major point was to elucidate how Ras and Raf1 are uncoupled 
from the Ras/Raf/Mek/Erk pathway in Chlamydia infection. 
The kinase activity of Raf 1 (Moelling, et al., 1984) has been shown to be regulated by 
phosphorylation of a highly conserved serine residue (Ser259) in the amino-terminal 
regulatory domain (Morrison and Cutler, 1997). Furthermore phosphorylation of Ser259 is 
shown to result in Raf1 inactivation as mutation of Ser259 to Ala constitutively activates the 
kinase activity of Raf1 (Rommel, et al., 1996) and this modification leads to binding of Raf1 
to 14-3-3β protein, a negative regulator of Raf1 (Zimmermann and Moelling, 1999). I 
therefore explored the possibility that the Akt kinase might directly phosphorylate Raf1 at 
Ser259 (Zimmermann and Moelling, 1999) leading to its inactivation in Chlamydia infection. 
Subsequently I could show a clear increase in the Raf1 phosphorylation at Ser259 in 
Chlamydia infected cells using a specific antibody on western blot. I could also confirm AKT 
as the responsible kinase for this phosphorylation (Figure 25Error! Reference source not 
found.). These results demonstrate the inactivation of Raf1 in normal Chlamydia infection of 
the host cells to be actively modulated by the pathogen for its benefit. This explains the 
increase of infectivity observed in the Ras and Raf1 knockdown conditions in the screen. 
It is reported that Chlamydia infection induces activation of PI3K /Akt pathway in host cells, 
which is speculated to be through secretion of effector proteins via the type III secretion 
apparatus directly or indirectly by oxidative or mechanical stress induced by infection 
(Verbeke, et al., 2006). PI-3 kinase and Akt pathway acts downstream of Ras and is known to 
regulate various cellular processes acting either synergistically with (Rodriguez-Viciana, et 
al., 1997) or in opposition to (Hu, et al., 1996) the Raf pathway. Several pro-apoptotic 
proteins have been identified as downstream targets of Akt. One of these is the Bcl-2 family 
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member Bad (Datta, et al., 1997; del Peso, et al., 1997). Phosphorylation of Bad triggers 
association with 14-3-3 proteins and loss of apoptotic activity in Chlamydia infections 
(Verbeke, et al., 2006). Akt also phosphorylates the forkhead transcription factor FKHRL-1, 
and as with Bad, this phosphorylation has been shown to led to its association with 14-3-3 
proteins and loss of FKHRL-1 function (Brunet, et al., 1999). Akt is also reported to 
antagonize Raf1 activity by direct phosphorylation of Ser259 of Raf1 (Zimmermann and 
Moelling, 1999). 
In Chlamydia trachomatis-infected cells, 14-3-3β is known to co-localize to the inclusion via 
direct interaction with a C. trachomatis encoded inclusion membrane protein IncG (Scidmore 
and Hackstadt, 2001). This taken together with the fact that Ser259 phosphorylated Raf1 
binds to 14-3-3β suggests that this IncG bound 14-3-3β might sequesters Raf1 to the 
inclusion membrane from the cytoplasm of the host cells. Conforming to this hypothesis, I 
could clearly demonstrate co-localization of the total Raf1 and p-Raf1 (Ser259) with 14-3-3β 
at the Chlamydia inclusion membrane (Figure 26). Furthermore, the re-localization of the 
Raf1 to the inclusion membrane was inhibited by knockdown of 14-3-3β and AKT (Figure 
27Error! Reference source not found.) indicating that this process to be actively regulated 
by Chlamydia by Ser259 phosphorylation of Raf1 through AKT. The inactivation of Raf1 by 
phosphorylation and its recruitment to the inclusion membrane through 14-3-3β indicates 
that Raf1 in its active state might be evoking a host cell response that might be unfavourable 
for Chlamydia survival in the host cell.  
In summary, I was able to successfully establish an assay to monitor the infection and 
infectivity of C. trachomatis in human cells. This in combination with the siRNA screening 
approach, I was able to identify several important host cell factors involved in the Chlamydia 
host cell interactions. Furthermore, through a mechanistic study I could clearly demonstrate 
that the Ras and Raf1 are not required for activation of Mek1/2 and downstream effectors 
and the uncoupling of Ras and Raf1 from Erk activation in Chlamydia infections. Additionally 
I have shown that the Raf1 is inactivated by phosphorylation through AKT and recruited to 
the Chlamydia inclusion in AKT and 14-3-3β dependent manner. However, the functional 
significance of Raf1 inactivation is still unclear at this stage. It can be speculated that 
Chlamydia specifically inactivates and sequesters the Raf1 to create conducive environment 
for its survival and replication by inhibiting downstream functions that Raf1 is involved in 
inducing. Thus, it is interesting to further investigate the functional relevance of Raf1 
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inhibition by Chlamydia on its survival, which might offer new possibilities to tackle the 
Chlamydia infections. Therefore, I have demonstrated in this study that the application of 
global RNAi screening approach can lead to identification of thus far unknown processes 
enabling a comprehensive understanding of the host-pathogen interactions. Besides, I are 
sure that further functional characterization of all or most of the important identified factors 
might unravel so far unknown and important host and Chlamydia interactions, which might 
help in broader understanding of the diseases caused by this pathogen to evolve better 
treatment strategies.  
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5 Materials and methods 
5.1 Materials 
5.1.1 Bacterial Isolates 
Chlamydia trachomatis LGV L2:   Lymphatic isolates (ATCC VR-902B) 
 
5.1.2 Cell lines  
HeLa human epithelial cells from cervical adenocarcinoma (ATCC CCL-2) were obtained from 
the American Type Cell Collection (ATCC). 
HeLa 229 human epithelial cells from cervical adenocarcinoma (ATCC CCL-2.1) were obtained 
from the American Type Cell Collection (ATCC). 
 
5.1.3 Cell culture media 
5.1.3.1 Growth medium (GM)  
Growth medium was used for the maintenance of HeLa cells and consisted of RPMI 1640 
with 2 mM L-glutamine and 25 mM HEPES (GibCo) supplemented with 10% FBS, heat 
inactivated (Biochrome). 
 
5.1.3.2 Infection medium (IM)  
Infection medium was used for performing Chlamydia infection experiments and consisted 
of RPMI 1640 with 2 mM L-glutamine and 25 mM HEPES (GibCo) supplemented with 5% FBS, 
heat inactivated (Biochrome). 
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5.1.4 Buffers and solutions  
5.1.4.1 Blocking Buffer for Immunoflourescence 
BSA (0.2%) in PBS 
 
5.1.4.2 PBS (10X) 
2 g/l KCl  
2 g/l KH2 PO4  
80 g/l NaCl  
11.5 g/l Na2 HPO4  
pH 7.4 
 
5.1.4.3 SDS-electrophoresis buffer (10x)  
1.92 M Glycine  
250 mM Tris/HCl  
1% SDS  
 
5.1.4.4 SDS loading buffer (4x, reducing)  
125 mM Tris/HCl pH 6.8  
6% SDS  
40% Glycerol  
10% -Mercaptoethanol  
2-10 mg Bromophenol blue  
 
5.1.4.5 SDS Stacking gel buffer (4x)  
6.05 g Tris/HCl  
0.4 g SDS  
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Add 100 ml H20  
Adjust to pH 6.8 with HCl  
 
5.1.4.6 SDS resolving gel buffer (4x)  
91 g Tris/HCl  
2.0 g SDS  
Add 500 ml H2O  
Adjust pH to 8.8 (with HCl)  
 
5.1.4.7 SPG buffer  
75 g Sucrose  
0.52 g KH2PO4  
1.22 g Na2HPO4  
0.72 g L-glutamic acid  
Fill up to 1 l with distilled water.  
Adjust pH to 7.4  
Sterile filter and store at 4 C 
 
5.1.4.8 TBS-buffer  
20 mM Tris/HCl  
140 mM NaCl  
pH 7.5  
For TBS-T, add 0.05% Tween 20  
 
5.1.4.9 Blocking buffer (Western blot)  
TBS-T  
3% milk powder 
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5.1.4.10 TBE buffer  
89.15 mM Tris/HCl  
88.95 mM Boric acid  
2 mM EDTA  
 
5.1.4.11 Western blot stripping buffer  
62.5 mM Tris/ HCl pH 6.7  
100 mM -Mercaptoethanol  
2% SDS  
 
5.1.4.12 Wet blot transfer buffer  
6 g Tris  
28.8 g Glycine  
2 g SDS  
20% Methanol  
Add up to 2 l H20  
 
5.1.4.13 Protein Marker 
PageRuler™ Plus Prestained Protein Ladder (Fermantas,  # SM1811) 
 
5.1.4.14 Mowiol embedding medium  
Mowiol 4-88 (2.4 g)   20% w/v  
Glycerol (6 g)    50% 
H 20 (6 ml) 
Tris/HCl pH 8.5(12 ml 0.2 M)  100 mM  
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Let swell over night;  
Heat to 50 C to dissolve;  
Optional: 10% w/v DABCO to slow down bleaching  
 
5.1.5 Fine chemicals 
Mek 1/2 Inhibitor U0126 (Sigma, # U120) 
Hoechst 33342 (Sigma, # B2261) 
 
5.1.6 Kits used in this study 
5.1.6.1 Sub-cellular fractionation kit 
For sub cellular fractionation of the cells, the ProteoExtract Subcellular Proteome Extraction 
kit (Calbiochem, # 539790) was used. The fractionation was performed as per the 
manufactures instructions. 
 
5.1.7 Primary antibodies 
Table 2: List of the primary antibodies employed in this study 
Antigen Species Dilution 
for IF 
Dilution for 
WB 
Company 
anti-Chlamydia MOMP Mouse 1:10000 - University of 
Washington 
anti - HSP 60 Mouse - 1:5000 Alexis, # 804-072-
R100 
Lamin a/c Mouse - 1:200 Chemicon, # 
MAB3211??? 
-Actin Mouse - 1:10000 Sigma, # A1978 
anti-c-Raf Rabbit 1:100 1:1000 Cell Signaling, # 
9422 
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anti-c-Raf Rabbit 1:100 1:500 Santa Cruz, # sc-
7198 
anti-Ras Rabbit - 1:1000 Cell Signaling, # 
3965 
anti-Phospho-cPLA2 Rabbit - 1:1000 Cell Signaling, # 
2831 
anti-cPLA2 Rabbit - 1:1000 Cell Signaling, # 
2832 
anti-Phospho-p44/42 MAPK 
(ERK1/2) 
Mouse - 1:2000 Cell Signaling, # 
9106 
anti-p44MAP Kinase (Erk1) Rabbit - 1:1000 Cell Signaling, # 
4372 
anti-phospho-cRaf(Ser259) Rabbit 1:100 1:1000 Cell Signaling, # 
9421 
anti-phospho-cRaf(Ser259) Rabbit 1:100 1:500 Santa Cruz, # sc-
101791 
anti – 14-3-3β Goat 1:100 - Santa Cruz, # sc-
17288 
anti – Cytokeratin 8 Mouse - 1:500 Santa Cruz, # sc-
58736 
anti –Lamp1 Rabbit - 1:1000 Cell Signaling, # 
3243 
anti-MEK1/2 Rabbit - 1:1000 Cell Signaling, # 
9126 
anti-Akt Rabbit - 1:1000 Cell Signaling, # 
9272 
anti-Calpain Rabbit - 1:1000 Cell Signaling, # 
2539 
 
5.1.8 Secondary antibodies 
Tabelle 3: List of the secondary antibodies employed in this study 
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Antigen Species 
Dilution for 
IF 
Dilution for 
WB 
Company 
anti-Mouse-Cy3 Goat 1:100 - 
Jackson ImmunoResearch, # 115-
165-146 
anti – Goat-Cy2 Donkey 1:100 - Dianove, # 705-225-147 
anti – Rabbit-
Cy5 
Goat 1:100 - Dianove, # 111-175-144 
anti – Rabbit-
HRP 
Donkey - 1:2000 Amersham, # NA934 
anti – Mouse-
HRP 
Sheep - 1:2000 Amersham, # NA931 
 
5.1.9 siRNA 
siRNAs were purchased from Qiagen, if necessary siRNA were validated at the Max Planck 
Institute for Infection Biology for their ability to knock down mRNA expression of target 
genes by more than 70% in comparison with control cells transfected with siRNA targeting 
luciferase. 
Tabelle 4: List of siRNAs used in this work (except the kinase and apoptosis libraries) 
Gene ID Number RefSeq Number 
ABI1 10006 AF540955.1 
ABI2 10152 U23435.1 
ABP-280 2316 X53416.1 
ACTN1 87 NM_001102.2 
AIF 9131 AF100928.1 
AKT1 207 NM_005163 
ALDH1A2 8854 NM_003888 
ALOX5 240 NM_000698.1 
ANP32A 8125 NM_006305 
AP1B1 162 NM_001127 
AP1M1 8907 NM_032493 
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AP1S1 1174 NM_001283 
AP1S2 8905 NM_003916 
Apaf-1 317 AF013263.1 
APG5L 9474 NM_004849.1 
APG7L 10533 NM_006395.1 
APO-1 355 X63717.1 
Apo-2 8743 U57059.1 
AQP5 362 NM_001651.1 
ARC34 10109 AF006085.1 
ARD-1 8260 X77588.1 
ARF1 375 NM_001658 
ARF3 377 NM_001659 
ARF4 378 NM_001660 
ARF5 381 NM_001662 
ARF6 382 NM_001663 
Arp3 10096 AF006083.1 
Asc2 23054 AF177388 
ATM 472 NM_000051.2 
ATP5B 506 X03559 
ATP5H 10476 NM_006356.1 
ATPsAC 498 X59066.1 
ATPsEC 514 NM_006886 
ATPsGC 509 NM_005174 
ATR 545 NM_001184.2 
Aven 57099 AF283508 
BAD 572 AF031523.1 
BAG1 573 NM_004323 
BAK1 578 NM_001188 
BARD1 580 NM_000465 
BAT1 7919 Z37166.1 
BBC3 27113 NM_014417 
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Bcl 2 596 NM_000633.1 
Bcl2A1 597 NM_004049.2 
BCL2L10 10017 NM_020396 
BCL3 602 NM_005178 
BCL6 604 NM_001706 
BCR 613 NM_004327 
BECN1 8678 NM_003766.2 
Bid 637 NM_197967 
BIK 638 U34584 
BimL 10018 AF032458 
BIRC6 57448 NM_016252 
Bmf 90427 AY029254 
BNIP1 662 U15172 
BNIP3 664 NM_004052 
BNIP3L 665 AF079221 
BOK 666 AF089746 
BRAF 673 NM_004333.1 (004333.2) 
BRCA1 672 NM_007294.1 
BWR1C 7262 AF035444 (AF019953) 
CALR 811 BC002500.2 
CARD8 22900 AF322184 
CASP1 834 NM_001223.2 
CASP10 843 NM_001230.2 
CASP3 836 NM_004346.2 
CASP4 837 BC017839.1 
CASP5 838 Nm_004347.1 
CASP6 839 NM_001226.2 
CASP7 840 NM_001227.2 
CASP8 841 NM_033358.1 
Casp9 842 NM_001229 
CAV1 857 NM_001753.3 
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CBX1 10951 NM_006807.2 
c-CBL 867 NM_005188 
CCND1 595 NM_053056.1 
CCNE1 898 NM_001238 
CCT2 10576 AF026293.1 
CD30 943 M83554.1 
CD36 948 NM_000072.1 
CD44 960 U40373.1 
CD46 4179 NM_002389.3 
cdk2 1017 X62071.1 
CDK4 1019 NM_000075 
CDKN1A 1026 NM_000389.2 
CDKN1B 1027 NM_004064 
CDKN1C 1028 NM_000076 
c-erb-B-2 2064 X03363.1 
CFL1 1072 NM_005507.1 
CHEK1 1111 NM_001274 
CHEK2 11200 NM_007194 
CHUK 1147 NM_001278.2 
c-IAP1 329 L49431.1 
c-IAP2 330 L49432.1 
CLTA 1211 NM_001833 
CLTC 1213 NM_004859.1 
COPB 1315 NM_016451 
CORO1A 11151 NM_007074.1 
CPSF5 11051 NM_007006.1 
CREB1 1385 NM_134442.2 
CRHSP-24 23589 AF115345.1 
CRK-II 1398 D10656.1 
CSA2 3550 AF182645.1 
CSK 1445 NM_004383.1 
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CTNNA1 1495 NM_001903.1 
DAXX 1616 NM_001350.2 
DAZAP1 26528 NM_018959.2 
DcR1 8794 AF012536.1 
DcR2 8793 AF023849.1 
DcR3 8771 AF104419.1 
DDX1 1653 NM_004939 
DHFR 1719 NM_000791 
DJ-1 11315 XM_001707.4 
DNER 92737 BC035009 
DNM2 1785 NM_004945 
DNMT1 1786 NM_001379 
DR3 8718 AF026070.1 
DR5 8795 AB014710.1 
DrpI 10059 NM_012062.2 
DSP 1832 NM_004415 
DUSP5 1847 NM_004419 
E2F1 1869 NM_005225.1 
E2F4 1874 NM_001950.3 
EEF1A2 1917 NM_001958 
EEF1B2 1933 NM_001959.2 
EEF1D 1936 NM_001960.2 
EGFRBP-GRB2 2885 M96995.1 
EIF2AK2 5610 U50648  NM_002759 
EIF3H 8667 NM_003756 
EIF4E 1977 NM_001968 
EIF5A 1984 NM_001970 
ELAVL1 1994 NM_001419.1 
ELK1 2002 NM_005229 
EMS1 2017 M98343.1 
EPHA2 1969 M59371 
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EZR 7430 BC013903.1 
FADD 8772 U24231 
FAK 5747 L13616 
FGFBP1 9982 NM_005130 
FLJ22625 79770 BC001615 
FLOT1 10211 NM_005803.2 
FRAP1 2475 NM_004958.2 
FTH1 2495 NM_002032.1 
FTL 2512 NM_000146.2 
FUBP1 8880 NM_003902.2 
FYN 2534 NM_002037 
G3BP 10146 NM_005754 
G3BP2 9908 AF051311 
GAB1 2549 U43885.1 
GABARAP 11337 NM_007278.1 
GADD45A 1647 NM_001924.2 
GADD45B 4616 NM_015675 
GADD45G 10912 NM_006705 
GLUD1 2746 NM_005271 
GMPS 8833 NM_003875.1 
GOLGB1 2804 NM_004487 
GRP58 2923 NM_005313 
GST-Pi 2950 X06547.1 
HADH2 3028 NM_004493.1 
HADHA 3030 NM_000182 
hAPG12 9140 AB017507.1 
hB23 4869 X16934 
HBE1 3046 NM_005330 
HBG1 3047 BC020719 
HCA56 1939 AF220417 
HDGF 3068 NM_004494.1 
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HEP06676 54888 AK000310.1 
hnRNP G 27316 NM_002139.1 (AY464692) 
hnRNP R 10236 AF000364.1 
HNRNPD 3184 D55671.1 
HNRNPH1 3187 L22009.1 
HNRPA0 10949 NM_006805.2 
HNRPA1 3178 XM_028653.1 
HNRPA2B1 3181 XM_004930.3 
HNRPAB 3182 NM_004499.2 
HNRPC 3183 NM_004500.2 
HNRPK 3190 NM_002140.2 
HNRPL 3191 NM_001533.1 
HNRPM 4670 XM_045150.1 
HNRPX 5093 U24223.1 
HRAS 3265 NM_005343 
HSABL 25 X16416.1 
HSBTF3B 689 X53281.1 
HSEGFPRE 1956 X00588 
HSP60 3329 M34664.1 
HSPA9B 3313 NM_004134.3 
HSPH1 10808 NM_006644 
HSPHAPI2A 10541 Y07569.1 
HSRAP1A 5906 X12533 
HSRHO2 397 X69549.1 
HSSCHAD 3033 X96752.1 
HSSYKPTK 6850 Z29630 
HSTRAPA 959 X68550.1 
HSTRR 7037 X01060.1 
HSU2AR 6627 X13482.1 
HUMASF 6426 M72709 
HUMBAXA 581 L22473.1 
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HUMCDPKTIA 5592 D45864 
HUMDLDH 1738 J03620 
HUMHFP 3185 L28010.1 
HUMKER1A 5595 M84490.1 
HUMLAMC 4000 M13451 
HUMPGES 5742 M59979.1 
HUMPSP45 5705 D44467.1 
HUMTRL 291 J02966 
HUMVINC 7414 M33308 
Ich-1 835 U13021.1 
IDH2 3418 NM_002168 
IDH3A 3419 NM_00553 
IER3 8870 S81914 
IFNB1 3456 NM_002176.1 
IKBKB 3551 AF080158 
IKBKE 9641 AF241789.1 
IKBKG 8517 AF261086 
IL8 3576 BC013615 
IL8RB 3579 NM_001557 
IMP 3615 J04208 
IMP-1 10642 NM_006546.2 
IMP-3 10643 AF117108.1 
IPAF 58484 AY035391 
IQGAP1 8826 NM_003870.2 
IRAK4 51135 NM_016123 
ITGA5 3678 NM_002205.1 
ITGB1 3688 NM_002211.2 
ITGB4 3691 NM_000213 
JIP2 23542 AF136382.1 
JKTBP 9987 D89092.1 
JNK1 5599 L26318.1 
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JNK2 5601 L31951.1 
JUN 3725 NM_002228.2 
JUND 3727 NM_005354 
K12H4.8 23405 AJ132261.2 
KHSRP 8570 NM_003685.1 
KIF1C 10749 U91329 
KIF20A 10112 NM_005733 
KIF3A 11127 BC045542 
KIF3B 9371 NM_004798 
KIF5B 3799 NM_004521 
KIF9 64147 NM_182902 
KIFAP3 22920 NM_014970 
KISS1 3814 NM_002256 
KIT1P 889 AF310133 
KRAS 3845 NM_004985 
LAMB2 84823 M94362.1 
LAMR1 3921 NM_002295.2 
LASP1 3927 NM_006148 
LCK 3932 NM_005356 
LDHA 3939 NM_005566.1 
LMNB1 4001 NM_005573 
MACF1 23499 NM_012090 
MAP1LC3A 84557 NM_032514.2 
MAP1LC3B 81631 NM_022818.2 
MAP2K1 5604 NM_002755 
MAP2K2 5605 NM_030662 
MAP2K4 6416 NM_003010.2 
MAP2K7 5609 NM_145185.1 
MAP3K14 9020 NM_003954.1 
MAP3K2 10746 NM_006609.2 
MAP3K5 4217 NM_005923.3 
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MAP3K7 6885 AB009357.1 
MAPK1 5594 M84489 
MAPK14 1432 NM_001315.1 
MAX 4149 NM_002382.3 
MCL1 4170 L08246 (AF118124) 
MDM2 4193 NM_002392.1 
MEFV 4210 NM_000243 
MEKK1 4214 AF042838.1 
MET 4233 NM_000245.1 
MKI67 4288 NM_002417.2 
MSN 4478 BC017293 
MSR1 4481 NM_138716, 
MTX1 4580 NM_002455 
MYC 4609 NM_002467.2 
MyD88 4615 U70451 
NACA 4666 NM_005594.1 
NAIP 4671 U19251 
NALP1 22861 AF310105 
NALP10 338322 AY154465 
NALP11 204801 AY154466 
NALP12 91662 AY154467 
NALP13 126204 AY154468 
NALP14 338323 AY154469 
NALP2/NALP7 55655 AF310106 
NALP3L 114548 AF468522 
NALP4 147945 AF442488 
NALP5 126206 AY154460 
NALP6 171389 AY154461 
NALP8 126205 AY154463 
NALP9 338321 AY154464 
NAP1RP 4673 NM_004537.3 (BT007023) 
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NCK1 4690 NM_006153 
NCL 4691 NM_005381.1 
NFKB1 4790 NM_003998.1 
NFKB2 4791 NM_002502 
NKEFA 5052 L19184 
NMHC 4627 M31013.1 
NMP200 27339 AJ131186.1 
nmt55 4841 U89867.1 
NOS1 4842 NM_000620 
NOS2A 4843 NM_000625 
NOS3 4846 NM_000603 
NRAMP2 4891 NM_000617 
NRAS 4893 NM_002524 
P1-Cdc21 4173 X74794.1 
p42 8666 AF020833 
p73 22062 Y19235 
PABPC4 8761 NM_003819.2 
PAFAH1B3 5050 NM_002573.2 
PAGE-5 90737 NM_130467 
Pak1 5058 U24152.1 
Pak2 5062 U24153 
PDGF 5159 J03278.1 
PFN1 5216 NM_005022 
PHB 5245 NM_002634 
PHLDA1 22822 Z50194 (NM_007350) 
PLA2G4A 5321 NM_024420 
PLCG1 5335 M34667.1 
PLEC1 5339 NM_000445 
por 7417 L08666.1 
PR264 6427 X62447.1 
PRDX2 7001 NM_005809 
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PRDX3 10935 NM_006793.2 
PRKCA 5578 NM_002737 
PRKCB1 5579 NM_002738 
PRKCD 5580 NM_006254 
PRKCE 5581 NM_005400 
PRKCG 5582 BC047876 
PRKCH 5583 NM_006255 
PRKCI 5584 NM_002740 
PRKCM 5587 NM_002742 
PRKCN 23683 NM_005813 
PRKCQ 5588 NM_006257 
PRKCZ 5590 NM_002744 
PSMA3 5684 NM_002788 
PSMA7 5688 BC004427 
PSMB1 5689 BC020807 
PSMC3 5702 NM_002804 
PSMC4 5704 NM_006503 
PSMD7 5713 NM_002811.2 
PSPC1 55269 AK001817.1 
PTBP1 5725 NM_002819.3 
PTEN 5728 NM_000314 
PTGS2 5743 NM_000963.1 
Rab 11B 9230 NM_004218 
Rab 1B 81876 NM_030981 
Rab 1C/Rab35 11021 NM_006861 
Rab 33A 9363 NM_004794 
Rab 6B 51560 NM_016577 
Rab 6C 84084 NM_032144 
RAB10 10890 NM_016131 
RAB11A 8766 NM_004663.2 
RAB1A 5861 NM_004161 
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RAB2 5862 NM_002865 
RAB30 27314 NM_014488 
RAB33B 83452 NM_031296 
RAB4A 5867 BC004309.1 
RAB5A 5868 NM_004162 
RAB6A 5870 NM_002869.2 
RABIF 5877 NM_002871 
RAC2 5879 M29870 
RAC2 5880 NM_002872.2 
RAD21 5885 X98294 
RAD23B 5887 NM_002874 
RAF1 5894 NM_002880.1 
RALY 22913 AF148457.1 
RB1 5925 NM_000321.1 
RBBP4 5928 X71810.1 
RBM14 10432 NM_006328 
RCC2 55920 AB040903 
RDX 5962 NM_002906 
RELA 5970 L19067 
RIPK2 8767 AF027706 
RPLP0 6175 NM_001002.2 
RPS18 6222 NM_022551 
RPS6KB1 6198 NM_003161.1 
SARA1 56681 NM_020150 
SEMG1 6406 NM_003007.1 
SEPT6 23157 NM_015129 
Serpin 5272 BC002538 
SF1-Bo 7536 Y08766.1 
SFN 2810 NM_006142.2 
SFPQ 6421 NM_005066.1 
SFRS9 8683 NM_003769.1 
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SHC1 6464 NM_003029.2 (003029.3) 
SH-PTP2 5781 L03535 
SIRT2 22933 NM_012237.2 
SKP1A 6500 NM_170679.1 
SLC3A2 6520 NM_002394.2 
SLC7A11 23657 NM_014331.2 
SMAC 56616 NM_019887.2 
SMARCE1 6605 NM_003079.3 
SMC1L1 8243 NM_006306 
SMPD1 6609 NM_000543 
SMPD2 6610 NM_003080 
SNW1 22938 U51432 
SOS1 6654 L13857.1 
SPTAN1 6709 NM_003127.1 
SRC 6714 NM_005417.2 
SSNA1 8636 BC015827 
STMN1 3925 NM_005563 
SURVIVIN 332 U75285.1 
SVIL 6840 NM_003174 
TAJ-alpha 55504 AF167555.1 
TBK1 29110 NM_013254.2 
Tensin3 64759 AF417489 
TES 26136 NM_015641 
TFR2 7036 AF067864.1 
TGFBR1 7046 NM_004612 
TGFBR2 7048 NM_003242 
TIA-1 7072 M77142.1 (NM_022037) 
TIAM1 7074 NM_003253 
TIP47 10226 NM_005817.2 
TJP1 7082 NM_003257.2 
TLN1 7094 AF078828 
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TLR1 7096 U88540.1 
TLR2 7097 U88878.1 
TLR3 7098 NM_003265.2 
TLR5 7100 AB060695.1 
TLR7 51284 NM_016562.2 
TLR8 51311 AF246971.1 
TLR9 54106 AF245704.1 
TNFa 7124 AF043342.1 
TNFRSF1A 7132 NM_001065.2 
TNFRSF1B 7133 NM_001066.2 
TNFRSF21 27242 NM_014452.3 
TNFRSF5 958 NM_001250.3 
TNFRSF7 939 NM_001242.3 
TNFSF18 8995 AF125303.1 
TNS1 7145 AF225896 
TNS2 23371 AF417490 
TOMM20 9804 NM_014765.1 
TOMM40 10452 NM_006114.1 
TOMM70A 9868 NM_014820.1 
TP53 7157 NM_000546.2 
TRA1 7184 NM_003299.1 
TRADD 8717 NM_003789.2 
TRAF1 7185 NM_005658.2 
TRAF2 7186 NM_145718.1 
TRAF3 7187 NM_003300.2 
TRAF4 9618 NM_004295 
TRAF5 7188 NM_004619 
TRAF6 7189 U78798 
TRIP9 4793 L40407 
TSG101 7251 NM_006292.2 
TUFM 7284 NM_003321 
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TXNL 9352 NM_004786 
U2AF2 11338 NM_007279.1 
ULK1 8408 AF045458.1 
USF1 7391 NM_007122.2 
USF2 7392 NM_003367.1 
USP10 9100 XM_033922.2 
VASP 7408 NM_003370.1 
VAV1 7409 NM_005428 
VDAC3 7419 NM_005662.3 
VDP 8615 NM_003715 
VEGFA 7422 X62568.1 
VEGI 9966 AF039390.1 
VIM 7431 NM_003380 
WT1 7490 NM_000378.2 
XIAP 331 U45880.1 
YES1 7525 NM_005433 
 
5.2 Methods 
5.2.1 Cell culture 
Cell lines were cultured in appropriate growth medium at 37 C in a cell culture incubator 
under humidified atmosphere containing 5% CO2. Presence of Mycoplasma spp. was 
excluded using the VenorGeM PCR assay. Before passaging, adherent cells (epithelial and 
endothelial cells) were washed once with PBS. 1.5 ml Trypsin (0.05%)-EDTA (0.53 mM) was 
added per 75 cm3 culture flask and cells were incubated at 37 C until they detached. Cells 
were resuspended in growth medium and transferred into fresh culture flasks in a 1:4 to 1:6 
dilutions. To maintain cells in culture and avoid complete confluence, cells were split every 
two to three days. 
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5.2.2 Preparation of Chlamydia stocks 
For the preparation of C. trachomatis stocks, the bacteria were propagated in HeLa cells 
grown in 150cm2 cell culture flasks with 24 ml of infection medium. 48 h after infection, the 
cells were detached using 3 mm glass beads. The cell suspensions were centrifuged at 500 × 
g and 4 C for 10 min (Hermle Labortechnik, Wehingen, Germany). The pelleted cells were 
then combined and ruptured using glass beads to ensure the breakage of cells. The lysates 
were centrifuged as before to sediment nuclei and cell debris. The supernatant was removed 
and recentrifuged at 20,000 × g for 40 min at 4 C in a SS-34 rotor (Sourvall Instruments, CT, 
USA) to pellet Chlamydia. The harvested bacteria were resuspended in 15 ml SPG buffer 
using a 21-22 gauge injection needle. Chlamydia suspensions were then aliquoted and frozen 
at -75 C and freshly thawed before each experiment. 
 
5.2.3 Assessment of infectivity titer 
Ten-fold serial dilutions of freshly thawed C. trachomatis stock EBs were prepared in 
infection medium and 250 µl of each dilution was inoculated onto a monolayer of HeLa cells 
cultured in 12-well plates. The bacteria were statically allowed to adsorb to cells for 2 h at 
5% CO2 and 37 C. After the adsorption period, cells were washed once with infection 
medium and then supplemented with 1 ml infection medium per well and incubated again 
under similar conditions. One day later, the cells were fixed, permeabilized and stained with 
the Chlamydia genus specific antibody (Error! Reference source not found.). The stained 
inclusions were counted at specific magnifications and the area of the microscopic field used 
with a micrometer slide (A) was estimated. The total area of the monolayer was estimated 
as well (B). Fields in the monolayer C= B/A. The number of IFU/ml can be calculated as 
follows: 
 
        No of IFU counted 
-------------------------------- × C × DF × V 
           No of Fields examined 
 
DF- dilution factor of EB preparation  
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V- Factor determined by the volume of the inoculum  
 
5.2.4 Infection with Chlamydia 
HeLa cells were infected with C. trachomatis at an MOI of 0.5 to 3 in infection medium and 
grown at 35 C and 5% CO2. Two hour post-infection the medium was replaced by fresh 
infection medium and incubated until fixed or used for lysis and reinfection. Infections in 96 
well plates were performed manually using an automated multichannel pipette from BioHit. 
5.2.5 Infectivity Assays  
5.2.5.1 Infectivity Assay in 96 well plate 
HeLa cells were infected as described before in 3.2.4. Two days post-infection, cells were 
lysed by adding Nonidet P40(NP40) at a final concentration of 0.06% for 15 min at room 
temperature, contents were mixed by pipeting up and down 5 times. Plates were subjected 
to shaking immediately after addition of NP40 and mixing after 15 minutes of incubation. 
Lysates were then diluted to 1:100 in infection medium before transfer to fresh untreated 
HeLa cells. After incubation for 24 h at 35 C and 5% CO2, the cells were fixed in ice cold 
methanol overnight at 4 C, subsequently cells were stained using indirect 
immunofluorescence protocol described below. 
5.2.5.2 Infectivity Assay in 6 well plates 
HeLa cells infected with C. trachomatis for 48 hours were scraped off the 6 well plates using 
a rubber policeman. The cells were collected in 15 ml falcon tube containing sterile glass 
beads and lysed by vortexing at 2500rpm for 3 minutes. Lysates were then diluted to 1:100 
in infection medium before transfer to fresh untreated HeLa cells. After incubation for 24 h 
at 35 C and 5% CO2, the cells were fixed in ice cold methanol overnight at 4 C, subsequently 
cells were stained using indirect immunofluorescence protocol described below. 
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5.2.6 Labeling using indirect fluorescent method  
The 96 well screen plates fixed with ice cold methanol were washed 2 times with PBS and 
then blocked using 0.2% BSA in PBS for 30 min at room temperature. Primary mouse anti C. 
trachomatis-MOMP KK12 (University of Washington) was added at 1:10,000 dilution in 
blocking solution for 1 h at room temperature, washed 2 times with PBS and Cy3-labeled 
goat anti-mouse IgG (Jackson ImmunoResearch) at 1:100 dilution in blocking solution was 
added for another hour. Host cell nuclei were stained with Hoechst 33342 (Sigma) diluted 
1:2000 in blocking solution of the secondary antibody. 
5.2.7 Double labeling of cRaf/p-cRaf and14-3-3β markers and confocal 
microscopy 
Infected host cells grown on coverslips were washed 2 times with PBS and then fixed with 
ice cold methanol overnight at 4 C. Cells were washed 2 times with PBS after discarding the 
methanol followed by blocking using 0.2% BSA in PBS for 30 min at room temperature. Next, 
the cells were incubated for 1 h at room temperature with mixtures of either cRaf and 14-3-
3β or p-cRaf and 14-3-3β primary antibodies in 100 µl of 0.2% BSA in PBS and then with the 
secondary fluorochrome-conjugated antibodies diluted in 0.2% BSA-PBS. Between 
incubation steps, cells were washed at least 3 times with PBS. Finally, the cover slips were 
washed and mounted using Moviol mounting medium on glass microscopic slides. Mounted 
specimens hardened at 4 C overnight and sealed with nail polish. The fluorochromes were 
visualized using filter set responsible for emission of 488 nm (FITC, green color) and 518 nm 
(rhodamine, red color) and a series of images with Z stacks were acquired using the laser 
scanning confocal microscope. The stacks were then analyzed using the Imaris Software. 
Finally the images were processed using Photoshop CS3 (Adobe Systems). 
 
5.2.8 Treatment with Mek1/2 inhibitor U0126 
For the experiment with Mek1/2 inhibitor U0126, 1 105 cells/well were seeded in 12 well 
plates 1 day before infection. Cells were infected with MOI 3 of C. trachomatis in 500 µl 
infection medium for 2 hours. After two hours the medium was replaced with 1 ml of fresh 
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infection medium containing either 10 or 100 µM U0126 inhibitor throughout the infection 
duration. 
 
5.2.9 siRNA transfection 
Transfection in 96 well plates was performed using the BioRobot® 8000 system (Qiagen) as 
follows: 1.5x103 HeLa cells/well were seeded in 96 well plates one day before transfection. 
For each well to be transfected 0.5 l from 2 M siRNA stock was re-suspended in 15 l of 
RPMI without serum and incubated for 10 minutes, to this 10 l of 1:20 diluted Hiperfect 
(Qiagen, Hilden) reagent was added and mixture was incubated for further 10 min. After 
incubation 25 µl/well of growth medium was added to the complex. Medium was removed 
from cultured cells and replaced with 50 µl/well fresh growth medium to this 50 µl/well of 
the transfection mixture prepared earlier was added leading to final siRNA concentration of 
10 nM. Cells were then incubated in 37 C and 5% CO2 incubator for 72h, which was 
determined to be the optimal time period for effective knock down of most of the target 
genes.  
For functional analysis experiments by Western blot and confocal microscopy: 1 105 
cells/well were seeded in 12-well plates 24 h prior to transfection and transfected using 
Hiperfect (Qiagen) according to the manufacturer's guidelines. In brief, 150 ng of specific 
siRNA was added to RPMI without serum and incubated with 6 µl Hiperfect transfection 
reagent in a total volume of 100 µl. After 10–15 min the liposome/RNA mixture was added 
to the cells with 1 ml cell culture medium leading to final siRNA concentration of 10 nM. 
After 1 day, cells were trypsinized and seeded into new cell culture plates depending on the 
experiments. Three days after transfection, the cells were infected and incubated as 
indicated above. 
5.2.10 Automated microscopy and image analysis  
chlamydial number, inclusion size and number of cells were analyzed in an automated 
microscope (Olympus Biosystems). Four pictures were taken from each well with a UV 
emission using blue filter and green emission with Cy3 filter at the same position. The 
images were analyzed for the number of cells and the number and size of chlamydial 
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inclusions by automatically identifying and counting using ScanR Analysis Software (Olympus 
Biosystems).  
5.2.11 SDS-PAGE   
SDS-PAGE was carried out using the vertical Biorad Mini-Protean II electrophoresis system. A 
stock solution of 30% acrylamide plus 0.8% bisacrylamide was used to prepare a 6 cm 
separating gel of 12% acrylamide and 2 cm stacking gel of 4.3% acrylamide. For 
polymerization of the gel, 0.1% TEMED and 0.5% APS were used.  
After brief centrifugation of the samples, 10 µl of each sample and 5 µl of prestained protein 
ladder were resolved on the 12% polyacrylamide gel at 75 V until the dye had run out of the 
stacking gel. The electrophoresis was then continued at 150 V for 50-60 min. The separated 
proteins were next detected and analyzed by Western blot technique.  
5.2.12 Western blot  
5.2.12.1 Preparation of cell lysates for Immunoblotting  
HeLa cells either with or without transfection depending on the experiment were grown in 
six-well plates, Infected with C. trachomatis L2 as described previously were washed with 
PBS. To this 200 µl of 1x SDS-Sample buffer (3% 2-mercaptoenthanol, 20% glycerin, 0.05% 
bromphenol blue, 3% SDS) was added. The lysate was collected in eppendorf tubes and 
heated in a boiling water bath or a heating block for 10. Samples were stored at – 20 C until 
used for further analysis 
5.2.12.2 Protein transfer  
Proteins separated by SDS-PAGE were transferred electrophoretically to Immobilon-P PVDF 
membranes using wet (tank) method of blotting in a Biorad electroblotting system (Biorad 
Mini Trans-Blot Electrophoretic Transfer Cell) according to (Towbin, et al., 1979). The 
membrane and 2 Whatman 3MM papers were trimmed nearly to the size of the separating 
gel. The Whatman papers and fiber pads were soaked in transfer buffer, while the PVDF 
membrane was soaked in methanol for 5 min for activation, washed with distilled water and 
soaked in transfer buffer. For protein transfer, polyacrylamide gel-membrane sandwich was 
arranged as follows: the gel was placed on a wetted sheet of Whatman paper already placed 
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on a well soaked fiber pad on the transfer cassette. The membrane was then placed on the 
gel, followed by sequential placing of another sheet of Whatman paper and a fiber pad over 
the membrane. Formation of air bubbles was avoided. Next, the transfer cassette was closed 
and inserted into the buffer tank containing a small stiring bar and a cooling unit with frozen 
distilled water. Finally, the transfer apparatus was placed on a magnetic stirrer, electrodes 
were attached and transfer was carried out for 3 h at 250 mA and 4 C or overnight at 100 
mA and 4 C.  
5.2.12.3 Immunoblotting  
Once protein transfer was completed, the membrane was transferred to a small container 
with 3% milk powder in TBS-T(blocking buffer) and incubated with shaking on a rocking 
device for 30 min at room temperature to block any remaining free-binding sites on the 
membrane. The membrane was then incubated with shaking for 1 h at room temperature or 
overnight at 4 C with primary antibodies diluted in blocking buffer. After 3 washings for 10 
min with TBS-T the bound primary antibodies were incubated with corresponding secondary 
antibodies conjugated to horseradish peroxidase (Amersham Biosciences and Jackson 
ImmunoResearch Laboratories) at appropriate dilution in blocking buffer. The membrane 
was washed 3 times for 10 min with TBS-T. The presence of immunoreactive proteins was 
detected on an X-ray Kodak film directly or using the AIDA Image Analyzer after soaking the 
membrane for 1 min in the chemiluminescence solutions 1 and 2 mixed 1:1 (ECL reagent, 
Amersham Biosciences). Band intensity was calculated using the AIDA Image Analyzer 
Version 4.03 software. If required the blots were stripped and probed with other antibodies. 
For stripping, the PVDF membranes were activated by incubating them with methanol for a 
minute and then washed with TBST for 5-10 min. Then about 200 ml of stripping buffer was 
added to these blots in the plastic boxes and incubated in a shaking water bath at 50 C for 
10 min. The blots were then transferred to new boxes and washed well with TBST for 1-2 h 
by changing TBST for every 20 min. The stripped blots were then incubated with blocking 
buffer followed by immunodetection as described earlier in this section. 
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 7 Appendix 
7.1 Abbreviations 
APS Ammonium persulphate 
ATCC American Type Culture Collection 
BSA Bovine serum albumin 
CO2 Carbon dioxide 
Ctr Chlamydia trachomatis 
DNA Deoxyribonucleic acid 
e.g For example (latin:'exempli gratia') 
EB Elementary body 
ECL Enhanced chemiluminescence 
EDTA Ethylenediaminetetraacetic acid 
EGF Epidermal growth factor 
FBS Fetal bovine serum 
FITC Fluorescein isothiocyanate 
g Gram 
GM Growth medium 
GO Gene Ontology 
h Hour 
H2O Water 
HEPES N-(2-hydroxyethyl)piperazine-N'-(2-ethanesulfonic acid) 
HIV Human immunodeficiency virus 
hpi Hours post infection 
HPV Human papillomavirus 
i.e. That is (latin: 'id est') 
IF Immunofluorescence 
IFU Inclusion forming unit(s) 
Ig Immunoglobulin 
IL8 Interleukin 8 
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IM Infection medium 
KD Knockdown 
l Liter 
LGV Lymphogranuloma venereum 
mA Milliampere 
MHC Major histocompatibility complex 
min Minute 
miRNA MicroRNA 
ml Milliliter 
mm millimeter 
mM Millimolar 
MOI Multiplicity of infection 
MOMP Major outer membrane protein 
mRNA MessengerRNA 
NP40 Nonidet P-40 
nt Nucleotide 
p.i Post infection 
PBS Phosphate buffered saline 
pH Negative decadic logarithm of the hydrogen ion 
concentration (latin: 'potentia hydrogenii') 
POC Percent of control 
PVDF Polyvinylidene fluoride 
RB Reticulate body 
RNAi RNA interference 
RNAi Ribonucleic acid 
RPMI Roswell Park Memorial Institute 
rRNA Ribosomal RNA  
SD Standard deviation 
SDS Sodium dodecyl sulfate 
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
shRNA Short hairpin RNA 
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siRNA Small interfering RNA 
SPG Sucrose–phosphate–glutamate 
STD Sexually transmitted diseases 
TBE Tris/Borate/EDTA 
TBS Tris Buffered Saline 
TBS-T Tris Buffered Saline with 0.5% Tween 20 
TEMED N,N,N',N'-Tetramethylethylenediamine 
TI Transfection infection 
TO Transfection only 
TTSS Type three secretion system 
UV Ultraviolet 
V Volume 
w/v weight/volume 
μl Micro liter 
μM Micromolar 
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